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Pharmaceutically active compounds (PhACs) have been detected in the aquatic 
environment as a result of loading from various sources. In Louisiana, USA, many municipalities 
treat wastewater using natural systems, such as lagoons and wetlands, rather than using 
conventional wastewater treatment technologies and may discharge PhACs into the environment.  
These treatment systems are not designed to remove PhACs from wastewater, nor is it currently 
a regulatory requirement. Research on the fate of PhACs in the environment is needed to 
understand impacts on Louisiana’s important coastal system. Wastewater sampling for PhACs at 
the Mandeville, LA wastewater treatment plant (WWTP) determined that this system 
significantly reduces the concentrations of PhACs prior to discharge into the environment. Most 
of the concentration reduction occurred in the first phase of treatment, where research suggests 
sorption may have been the major removal pathway. A wetland soil similar to the forested 
wetland at the Mandeville WWTP was tested for sorption and desorption of ciprofloxacin, 
ofloxacin and norfloxacin.  Two HPLC methods were developed for compound analyses in this 
experiment.  It was determined that sorption to wetland soil is a major and potentially long-term 
removal pathway for these pharmaceutical compounds from wastewater. The presence of 
antibiotics in the environment may have the ability to alter the microbial community in soils. We 
observed the greatest effect of antibiotics on soil microbial respiration followed this trend: 
sulfamethoxazole>ciprofloxacin>tetracycline. Most antibiotic effects were seen in the mineral, 
not the peat soil. Suppression of microbial respiration was observed, at low or high 
concentrations, depending on the antibiotic and soil examined. This result indicates that 
antibiotics can have negative impacts on microbial functions in treatment wetlands at 
“environmentally relevant” concentrations. Based on the findings of these studies, WWTPs 
xv 
 
systems similar to the Mandeville plant are effective at reducing the concentrations of many 
PhACs discharged into surface waters.  Furthermore, sorption appears to be a major pathway for 
this concentration reduction. However, antibiotics showed the potential to exhibit a negative 
influence on microbial activity in wetland soil. These natural treatment systems appear to be 
ideal for effectively treating PhACs in surface waters.
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CHAPTER 1: INTRODUCTION 
 
1.1. Introduction 
The presence of pharmaceuticals in the environment is an area of research that has 
recently garnered worldwide attention (Ternes, 1998; Daughton and Ternes, 1999; Kolpin et al., 
2002; Ternes et al., 2002; Webb et al., 2003). Past and current research has focused on 
wastewater treatment plant (WWTP) treatment capacity, soil and aqueous concentrations, 
sorption, desorption and toxicology (Halling-Sørensen et al., 2002; Miao et al., 2004; Bendz et 
al., 2005; Kolz et al., 2005; Pan et al., 2009).  Reduced cost, increased accuracy and decreased 
analysis time has spurred research in this field and lead to a greater understanding of the 
presence, transport and fate of pharmaceutically active compounds (PhACs) in the environment 
(Kolpin et al., 2002).  
PhACs enter the environment through a variety of pathways (Figure 1.1), with human 
excretion being a major source (Hirsch et al., 1999). Most pharmaceuticals are not completely 
absorbed by our bodies, and the remaining parent compound and its associated metabolites are 
excreted though urine and feces.  The same can be said for livestock treated with veterinary 
medicines.  While agricultural pharmaceuticals are released in the environment via farms, stock 
yards and sludge application, human PhACs are generally released through septic systems or 
WWTP effluents (Hirsch et al., 1999).  
As technology to monitor and detect PhACs has improved, the scope and scale of our 
understanding of the issue has grown. Research has branched out to examine toxicological 
effects of these compounds at low and high trophic levels (Stuer-Lauridsen et al., 2000; Webb et 




Figure 1.1. Potential pathways for PhACs to enter the environment. Adapted from Hirsch 
et al. 1999.  
of small mouth bass was altered in rivers feeding the Potomac River, possibly as a result of 
endocrine disruptors (Chambers and Leiker, 2006).  A study was also conducted that showed that 
the anti-inflammatory drug diclofenac was responsible for vulture population decline in Pakistan 
(Oaks and Gilbert, 2004). PhACs have also been found to affect algae and microbes (Halling-
Sørensen, 2001; Isidori et al., 2005). While PhACs have been detected in drinking water, to the 
author’s knowledge, there have been no studies demonstrating that exposure to pharmaceuticals 
in the environment and in drinking water has negatively impacted humans.  
Hundreds of drugs are prescribed worldwide, and new compounds are constantly being 
developed for human, veterinary and agricultural uses.  In Germany in 1995, 100 tons of 
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prescription drugs were purchased (Ternes, 1998).  This number does not account for the number 
of over the counter and veterinary medicines that were used (Ternes, 1998).  The average 
number of prescriptions and nonprescription drugs dispensed during doctor visits has risen from 
189.8 per 100 people in the U.S. population during 1995-1996 to 226.4 from 2003-2004 (NCHS, 
2006).  The percentage of the US population using a prescription drug each month has risen from 
39.1%  between 1988-1994 to 45.3% from 1999-2002 (NCHS, 2006).   
Due to the widespread usage of pharmaceuticals in the world, numerous drugs have been 
detected in the environment. Advances in analytical instrumentation have lead to the ability to 
extract and measure PhAC concentrations in the environment down to the parts per trillion (pptr) 
level.  As detection limits decrease, there is an increase in the likelihood of detecting and 
quantifying compounds, which will ultimately lead to a greater understanding of the processes 
that influence the fate of PhACs.  Many studies have focused on measuring compounds in the 
environment and removal or persistence with specific water treatment processes.  A short list of 
these drugs, along with measured concentrations, removal rates, removal processes and drug 
classes are listed in Table 1.1.  Data in the table also shows that the range of compound 
concentrations varies greatly from study to study.   
In order to determine the existence and concentrations of pharmaceuticals in 
environmental samples, advanced techniques have been developed to extract, concentrate, and 
identify these compounds.  Concentrations of PhACs are generally found in the environment in 
the parts per billion (µg L-1) or pptr (ng L-1) range.  Therefore, detecting a PhAC in a water 
sample must involve extraction and concentration of the target compound.  Two commonly used 
methods are solid phase extraction (SPE) and passive sampling. SPE methods have been 
developed to target the removal of individual compounds or groups of compounds from samples 
(Koutsouba et al., 2003; Moldovan, 2006; Vieno et al., 2006).  For SPE, the PhAC compounds 
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Table 1.1. Select pharmaceutical compounds detected in the environment along with their percent reduction and water treatment 
method. 
Select PhACs in the Environment 
Drug Reduction 
Environmental 
Concentration Treatment Method Drug Use Study 
Acetylsalicylic acid 81% 0.220 µg/L STP removal Aspirin (Ternes, 1998) 
Bezafibrate 83% 2.200 µg/L STP removal Lipid Regulator (Ternes, 1998) 
Caffeine 94% 
 
STP Removal Stimulant (Bendz et al., 2005) 
Caffeine >99% 0.190 µg/L STP removal Stimulant (Ternes et al., 2001) 










Antibiotic (Hirsch et al., 1999) 





Lipid Regulator (Webb et al., 2003) 
Diclofenac 69% 0.810 µg/L STP Removal Analgesic/Anti-inflammatory (Ternes, 1998) 
Diclofenac 22% 0.160 µg/L STP Removal Analgesic/Anti-inflammatory (Bendz et al., 2005) 
Fenofibric acid 64% 0.380 µg/L STP Removal Lipid Regulator (Ternes, 1998) 
Gemfibrozil 67±51% 0.000-0.180 µg/L Santa Anna River Lipid Regulator (Gross et al., 2004) 
Ibuprofen 90% 0.370 µg/L  STP Removal Analgesic/Anti-inflammatory (Ternes, 1998) 
Ibuprofen 47±37% 0.001-0.023 µg/L Santa Anna Wetland Analgesic/Anti-inflammatory (Gross et al., 2004) 
Naproxen 66% 0.300 µg/L STP Removal Analgesic/Anti-inflammatory (Ternes, 1998) 
Naproxen 100% 0.000-0.105 µg/L Santa Anna River Analgesic/Anti-inflammatory (Gross et al., 2004) 
Propranolol 32% 0.050 µg/L STP Removal Anti-epileptic (Bendz et al., 2005) 
Propranolol 96% 0.170 µg/L STP Removal Anti-epileptic (Ternes, 1998) 
Triclosan 97-99%   Activated Sludge Treatment Antibacterial Agent (Waltman et al., 2006) 




are extracted and concentrated from a pre-determined volume of sample. Passive sampling 
involves the use of a sorption medium that is deployed in the environment for a pre-determined 
amount of time. As water moves across the medium, target PhACs accumulate on sorbents in the 
sampler, which are later extracted for analysis (Petty et al., 2004; Alvarez et al., 2008). The 
instrumentation used to analyze these compounds is usually a gas (GC) or liquid (LC) 
chromatograph.  These instruments are usually coupled with mass spectrometers (single or 
tandem), ultra-violet/visible spectrometers and/or fluorescence detectors.   
1.2. Mississippi River and Davis Pond Pilot Study 
Pharmaceuticals and personal care products have been detected in the Mississippi River 
(Zhang et al., 2007). A pilot study was conducted in February of 2007 to determine 
concentrations of a suite of pharmaceuticals in the Mississippi River at the locations north and 
south of Baton Rouge and at the inflow to both the Davis Pond and Caernarvon freshwater 
diversions (Figure 1.2).  Samples were also taken at the midpoint of the Davis Pond diversion 
ponding area and the outfall into Lake Cataouatche to determine if the diversion wetland could 
be a potential tool for removal of pharmaceuticals from river water.  
Water samples were filtered to remove particulates and the compounds of interest were 
extracted using solid phase extraction, which is discussed more extensively in Chapter 2.  
Samples taken from the Mississippi River, both north and south of Baton Rouge and New 
Orleans also contained trace amounts of PhACs. Sample concentrations were averaged for all 
sampling sites and potential compound discharge into the Gulf of Mexico was calculated using 
the average river discharge rate of 450,000 ft3 s-1 (12,750 m3 s-1). The calculations demonstrate 
that even when only a trace amount of a contaminant is detected, due to the volume and 
discharge rate of the Mississippi River, the total mass of contaminant equates to several metric 




Figure 1.2. Sampling locations in the Mississippi River during February of 2007. 
Table 1.2. Mississippi River concentrations and discharge into the Gulf of Mexico based on 






µg L-1 metric ton yr-1 
Cotinine 0.014 5.5 
Caffeine 0.071 28.7 
Carbamazepine 0.014 5.8 
Fluoxetine 0.006 2.6 
Naproxen 0.007 2.8 
Ibuprofen 0.010 4.0 
Sulfamethoxazole 0.028 11.4 
 
Caffeine, contained in many common drinks and medicines, had the highest annual loading at 
nearly 29 metric tons a year.  These samples were tested for 15 compounds, but only 7 were 
detected.  The compound that was detected at the lowest concentration (fluoxetine) had a 
potential annual discharge rate of 2.6 metric tons to the Gulf of Mexico.   
Of the 15 compounds that were under investigation, only 5 were detected in the inflow to 
Davis Pond, while 3 other drugs were detected at either the midpoint in Davis Pond or the outfall 
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into Lake Cataouatche (Table 1.3). All concentrations of detected compounds were less than 0.1 
ppb (µg L-1). Based on the concentrations observed, the Davis Pond diversion could potentially 
reduce loading to coastal waters by 73 kg annually. The diversion wetland potentially has the 
ability to reduce the PhAC compound concentrations, based on the estimates of percent removal 
near 100%. The designed use of the diversion is to control salinity in the Barataria Basin, but this 
initial screening demonstrates that it could also function to reduce some contaminants, 
specifically pharmaceuticals, in the Mississippi River water that is diverted into coastal 
Louisiana. 
Table 1.3. Pharmaceutical concentrations measured for the Davis Pond freshwater 
diversion in February of 2007 and their loading and concentration reduction rates. 
 









µg L-1 kg yr-1 
Cotinine 0.013 0.013 b.d. 19 0 >99% 
Caffeine 0.075 0.081 0.024 108 35 68% 
Carbamazepine 0.021 0.023 b.d 30 0 >99% 
Fluoxetine 0.006 b.d b.d 9 0 >99% 
Acetaminophen b.d 0.045 b.d 66 0 >99% 
Naproxen b.d 0.007 b.d 10 0 >99% 
Ibuprofen 0.010 b.d b.d 14 0 >99% 
Sulfamethoxazole b.d b.d 0.010 0 15 0% 
b.d.: below detection 
 The Mississippi River contains a significant amount of contaminants that are discharged 
into the Gulf of Mexico (Boyd et al., 2003; Zhang et al., 2007).  The use of recycled wastewater 
for drinking water is a controversial subject.  Many municipalities directly or indirectly discharge 
treated wastewater into the Mississippi River, which likely contains pharmaceuticals and 
personal care products.  New Orleans, LA, which utilizes the Mississippi River for some portion 
of its drinking water. The water is treated prior to consumption but the treatment is not designed 
to remove these compounds. The use of a diversion, such as Davis Pond, to reduce aqueous 
pharmaceutical concentrations would be a large scale effort to reduce loadings from the 
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Mississippi River into the Gulf of Mexico.  However, communities along the river might also 
decrease their discharge of these compounds through the implementation of more efficient 
wastewater treatment systems or a tertiary treatment system such as a natural or constructed 
wetland  This would decrease the potential for drinking water contamination in cities that use the 
Mississippi River as a drinking water source. 
1.3. Conventional and Natural Wastewater Treatment 
Communities in Louisiana use natural treatment systems to treat wastewater along with 
natural wetlands to polish and remove excess nutrients prior to discharge into rivers and lakes. 
While wetland treatment systems are excellent for nutrient and biological oxygen demand (BOD) 
reduction (Day et al., 2004), it has recently been shown that they are also effective at reducing 
aqueous concentrations of pharmaceuticals in wastewater (White et al., 2006; Matamoros et al., 
2008). 
In Mandeville, LA, located on the north shore of Lake Pontchartrain, the wastewater 
treatment systems consists of three earthen detention basins with aeration fountains,  a 
constructed wetland with native vegetation and UV treatment.  The treated wastewater then 
flows into Bayou Chinchuba before discharge into Lake Pontchartrain.  This constructed system 
treats wastewater for a period of ~14 days before discharge into the Bayou for further removal of 
nutrients and BOD. This system contains several wastewater treatment technologies that are 
utilized by conventional plants, but has a longer retention time and the potential for greater 
treatment at the soil/water interface. Natural systems are desirable to communities because the 
construction costs are a fraction of conventional plants and they can be as efficient at achieving 
regulatory requirements for wastewater discharge.  However, these systems generally require 
more land area, have less treatment capacity and take longer to achieve treatment levels of 
conventional treatment plants. 
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Many conventional treatment plants utilize constructed concrete detention basins which 
combine physical mixing, aeration, particulate precipitation and some form of disinfection 
technology to sterilize the water. Treatment of wastewater in these plants generally takes less 
than a few days, compared to the 2 weeks in the Mandeville system. 
1.4. Aqueous Environmental Removal Mechanisms 
In the environment, there are various mechanisms that impact the removal or degradation 
of PhACs.  The effectiveness of these mechanisms varies with the physical properties of each 
individual compound and environmental conditions.  While research has not been conducted to 
determine the physical properties that affect the fate of every PhAC in the environment, studies 
have shown that many processes play roles in treatment and degradation of these compounds in 
the environment.  Some of these mechanisms are sorption, desorption, reduction, oxidation, 
temperature, pH, photolysis and complexation with minerals such as magnesium and iron (Tolls, 
2001; Zhang and Huang, 2003; Vogna et al., 2004; Scheytt et al., 2005; ter Laak et al., 2006; 
Zhang and Huang, 2007). These varied mechanisms and soil properties collectively play a large 
role in aqueous concentration reductions within wastewater treatment plants and wetlands. 
Sorption of pharmaceuticals to environmental medium, such as soil (mineral and organic) 
and suspended particulates is known to be a significant removal pathway for many compounds 
from the aqueous phase (Bonin and Simpson, 2007; Gu et al., 2007; Pan et al., 2009). However, 
there are compounds (i.e. carbamazepine) that appear to be more persistent in the environment, 
due to their low sorption potential (Andreozzi et al., 2002; Miao et al., 2005; Williams et al., 
2006).  
Within the Mandeville WWTP and wetland, there are significant amounts of organic 
materials (fecal matter) within the plant to sorb pharmaceuticals.  However, the use of earthen 
detention ponds and a constructed and natural wetland to treat wastewater provides another 
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sorption medium, soil, not found in conventional concrete treatment plants. Therefore, the 
Mandeville treatment system provides a wider range of sorption sites (mineral and organic) than 
can be found in conventional treatment systems. This range of sorption sites, coupled with longer 
hydrologic retention times may make natural treatment systems more effective at reducing the 
aqueous concentrations of pharmaceuticals. 
Each pharmaceutical has unique properties that influence its sorption potential, which 
will also vary with soil properties.  Therefore, when measuring a single compound’s sorption 
potential, the distribution coefficient (KD) will only apply to that medium at that particular 
concentration. In order to gain a more generalized range of sorption potentials, a compounds KD 
must be measured over a wide range of concentrations. The two most widely used models for 
describing compound behavior are the Langmuir and Freundlich isotherms. The following 
assumptions must be met to use the Langmuir isotherm; 1) adsorption must be a monolayer, 2) 
homogenous sorption surface, and 3) the sorption of a molecule is not influenced by the 
occupation of neighboring sorption sites.  The assumptions of the Langmuir isotherm are not 
likely to apply to soils and sediment found in a wetland and treatment plant due to the 
heterogeneity of the sorption medium. Therefore, the Freundlich isotherm should be used when 
examining wetland soils. The Freundlich isotherm is an empirically derived coefficient obtained 
by plotting the Log of the amount sorbed to the soil, by the Log of the concentration in solution 
at equilibrium.  The points are then fitted with a linear trendline and the y-intercept serves as the 
Freundlich coefficient (KF). Higher values indicate higher sorption potential and generally values 
>3.5 are considered highly sorptive. 
There has been a significant amount of research on the sorption of many pharmaceutical 
compounds (Pouliquen and LeBris, 1996; Kan et al., 2000; Thiele-Bruhn, 2003; Hildebrand et 
al., 2006; Bonin and Simpson, 2007). However, many studies address sorption to standard 
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substances (Gu and Karthikeyan, 2005; Zhang and Dong, 2008) and competition between 
compounds for binding has only been examined for traditional pollutants such as pesticides and 
herbicides (Pignatello et al., 2006; Shechter et al., 2006). In wastewater it has been demonstrated 
that many compounds are usually present, with the likelihood that many more are not detected 
(Bedner and MacCrehan, 2006; Gros et al., 2007; Kummerer, 2009b). While soils possess 
numerous sorption sites, the presence of multiple compounds in wastewater may lead to 
competition between compounds for specific binding sites. 
1.5. Pharmaceutical Impacts on the Environment  
While a significant amount of research has been conducted to detect and begin to 
understand the fate of PhACs in the environment, more is needed to address their potential 
impacts. There are hundreds of compounds and each has its own unique properties, resulting in 
varying reactions to environmental conditions and potential biological effects to organisms.  
Research has shown that discharged wastewater usually contains a suite of compounds (Kolpin 
et al., 2002; Watkinson et al., 2007), which may also lead to impacts as a result of multiple drug 
interactions. Many studies have examined the toxicological effects of these compounds on plants 
(Halling-Sorensen, 2000; Andreozzi et al., 2002), animals (Oaks and Gilbert, 2004; Chambers 
and Leiker, 2006) and microbes (Kummerer et al., 2000; Gu et al., 2002; Jiao et al., 2008). 
Microbial antibiotic resistance has garnered significant attention and it has been shown that 
microbes in the environment have developed resistance to many antibiotic compounds 
(Tendencia and de la Pena, 2001; Chelossi et al., 2003; Baker-Austin et al., 2008). However, the 
impacts of pharmaceuticals on microbial community activity is less well studied (Fountoulakis, 
2004; Costanzo et al., 2005). 
Wetland soils support a wide range of microbial communities, which are responsible for 
many ecosystem processes, including organic matter decomposition and nutrient cycling (Wright 
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and Reddy, 2001). The microbial community structure and activity is tied to the efficiency of 
nutrient cycling and ecosystem function (Yao et al., 2000). Many environmental factors, such as 
pH, organic matter composition, and nutrients, influence the microbial community structure (Ye 
et al., 2009). Physical (Wright et al., 2007) and chemical (Girvan et al., 2004) disturbances  are 
known to alter the microbial community structure in soils. While there has been significant 
research on the effects of pesticides and herbicides on microbial activity (Chatterjee et al., 2010; 
Wang et al., 2010), relatively little has examined pharmaceutical effects, especially in wetlands. 
Antibiotics, which are used to treat and prevent bacterial infections in humans and 
livestock, have been routinely detected in the environment (Hirsch et al., 1999; Haggard and 
Bartsch, 2009). Therefore, there is reason to believe that antibiotics may impact microbial 
function and community structure in environmental systems. A simple metric for determining an 
antibiotic impact in wetland soils is to measure the soil respiration. Gas evolution is a result of 
microbial respiration or activity, which produces CO2, CH4 and N2 gas. If the addition of an 
antibiotic alters the soils respiration rate, then it has altered the microbial activity, which may 
impact organic matter decomposition and nutrient cycling. While, there has been little research 
on the effects of antibiotics on microbial activity, research has determined that many bacteria 
found in the environment posses resistant genes to commonly used human and agricultural 
antibiotics (Boon and Cattanach, 1999; Baker-Austin et al., 2008). However, it remains to be 
studied how long it may take resistance to develop in the environment or for the community 
structure to change once an antibiotic is added to the system. 
1.6. Hypothesis 
The research presented in this dissertation sought to examine the fate, transport and 
microbial effects of pharmaceutical compounds in a treatment wetland. Studies focused on 
compounds entering wetlands and surface waters in Southeast Louisiana and their removal by 
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wetland processes. Research also includes laboratory studies to understand the fate of these 
compounds through sorption and desorption and the effects of antibiotics on wetland soil 
microbial respiration (CO2, CH4 and N2 production).  
Natural wetland treatment systems will remove pharmaceuticals from domestic 
wastewater in amounts that are equal or greater than conventional wastewater treatment systems, 
and the major mechanism for removal (for most compounds) is sorption to particulates and 
sediments. The presence of multiple antibiotic compounds in a wetland can also result in 
competition for preferred binding sites between the compounds studied. Antibiotics will reduce 
the microbial activity in treatment wetlands. However, sorption may decrease the impact of 
antibiotics on wetland soil microbial communities. In addition, wetland soils that have previously 
sorbed pharmaceuticals may act as a source of pharmaceuticals if loading concentrations are 
decreased or stopped. 
1.7. Synopsis of Chapters 
 In Chapter 2, the effectiveness of a “natural” wastewater treatment system in Mandeville, 
LA that uses earthen retention basins, constructed and natural wetlands along with aeration and 
UV exposure to treat wastewater over a ~14 day period is examined. Comparisons were made 
between this system and more conventional systems with regards to the reduction of aqueous 
concentrations of pharmaceuticals in wastewater. Individual treatment phases were also studied 
to determine their effectiveness, especially the natural treatment wetland. Estimations of the total 
annual loading and removal were calculated based on the concentrations observed. 
 After examining pharmaceutical removal in a full-scale wastewater treatment system in 
Chapter 2, it was decided to further examine sorption as a potential aqueous removal pathway for 
Chapter 3 and 4. While several analytical methods were available in the literature to detect the 
three fluoroquinolone (ciprofloxacin, norfloxacin, ofloxacin) antibiotic compounds, new 
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methods were needed in order to analyze samples and efficiently complete the experiment. In 
Chapter 3, HPLC methods were developed to analyze the three compounds both individually and 
simultaneously for use in determining sorption potentials.  Chapter 4 presents the sorption and 
desorption potential of three antibiotics over a concentration range of 20 to 80 ppm, which 
simulates the long-term loading that a treatment wetland may experience over decades. 
Competition was examined between a three-compound mixture at 20 ppm of each compound and 
compared it the individual sorption potentials at 60 and 20 ppm.  These comparisons shed light 
on sorption interactions when multiple compounds are present in the aqueous phase, which is 
common in wastewater effluent. 
 After examining the presence of pharmaceuticals in a wastewater treatment system and 
studying sorption as a major removal pathway, potential antibiotic effects on the microbial 
activity in a treatment wetland soil were determined in Chapter 5.  Three widely used antibiotics 
(ciprofloxacin, tetracycline, sulfamethoxazole) were added to two wetland soils (peat, mineral) at 
“environmentally” relevant concentrations to examine effects on microbial activity. The 
evolution of CH4, CO2 and N2 was measured for basal and substrate induced respiration (non 
carbon limited and also non nitrogen limited for N2).  Implications of all the research chapters 




CHAPTER 2: REDUCTION OF PHARMACEUTICALLY ACTIVE 
COMPOUNDS BY A LAGOON-WETLAND WASTEWATER 





The fate of pharmaceutically active compounds (PhACs) in the aquatic environment is an 
emerging area of research (Ternes, 1998; Daughton and Ternes, 1999; Kolpin et al., 2002; 
Ternes et al., 2002; Webb et al., 2003; Kolpin et al., 2004; Jones et al., 2005a). A significant 
portion of this research has focused on the capacity of wastewater treatment plants (WWTPs) to 
remove PhACs from wastewater, and the contribution of WWTPs to PhAC loadings to receiving 
waters (Heberer et al., 2002; Boyd et al., 2003; Miao et al., 2004; Bendz et al., 2005; Joss et al., 
2006; Lishman et al., 2006; Gobel et al., 2007).  However, there are very few data on the ability 
of constructed wetlands and natural wetland systems to reduce the concentrations of 
pharmaceuticals before the release of wastewater into aquatic systems (White et al., 2006; 
Matamoros et al., 2008).   
PhACs enter the environment through a variety of pathways, and the human body plays a 
major role.  A portion (varies by drug and individual) of each pharmaceutical dose is retained in 
the human body, but residual parent compound and its metabolites are excreted in urine and 
feces (Daughton and Ternes, 1999; Khetan and Collins, 2007; Lienert et al., 2007). The PhACs 
are then released either through septic systems or in wastewater effluents (Jones et al., 2005b). 
Within wastewater treatment plants and in the natural environment, the rates of degradation of 
PhACs vary, depending on the chemical and physical properties of each compound, and 
environmental conditions (Jones et al., 2005b). Physical, chemical and biological parameters that 
influence degradation include; sorption/desorption, redox potential, temperature, pH, photolysis, 
                                                          
1 Re-print with permission from Elsevier, Appendix A 
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microbial activity, and select minerals (Tolls, 2001; Zhang and Huang, 2003; Vogna et al., 2004; 
Scheytt et al., 2005; ter Laak et al., 2006; Zhang and Huang, 2007).  
It has been predicted that the discharge of pharmaceuticals into the environment will 
increase over time (Jones et al., 2005b). For example, in Germany in 1995, 100 tons of 
prescription drugs were purchased, which does not account for sales of non-prescription drugs 
and veterinary medicines that were used (Ternes, 1998).  As a result of greater reliance on 
pharmaceuticals and an aging population, the number of prescription and nonprescription drugs 
dispensed during doctor visits has risen from 190 per 100 people in the USA during 1995-1996 
to 226 during 2003-2004 (NCHS, 2006).  Monthly prescription drug usage as a percentage of the 
USA population has risen from 39.1% during 1988-1994 to 45.3% during 1999-2002 (NCHS, 
2006).   
Southeast Louisiana has been shaped by deltaic processes over several hundreds of years 
by the meandering of the Mississippi River.  The majority of this region is near, at or below sea 
level.  Due to the low elevation, much of the area is covered by freshwater wetlands and marsh. 
The Mississippi River, which receives treated wastewater from urban centers within the 
watershed, has the potential to carry significant amounts of contaminants, including PhACs into 
the coastal waters of Louisiana and the Gulf of Mexico. There is an opportunity in this region to 
utilize the natural wetlands to provide a final level of treatment (i.e. “polishing”) to wastewater, 
prior to release into surface waters.  These wetlands can be used to naturally remove nutrients, 
organic loads and contaminants, while other areas of the USA must use advanced treatment 
technologies to achieve the same level of removal.  The drawback is that significantly longer 
retention times are required for natural systems versus conventional wastewater treatment 
systems due to slower treatment processes.  
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Constructed wetlands are effective at removing or reducing the concentrations of 
nutrients (Braskerud, 2002), pathogens (Karim et al., 2004) and microcontaminants, such as 
endocrine disruptors, PhACs and personal care products (Belmont and Metcalfe, 2003; 
Matamoros et al., 2005; Matamoros and Bayona, 2006; Waltman et al., 2006; White et al., 2006).  
Natural wetlands are known to mitigate the effects of both point and non-point source pollution 
(Johnston et al., 1990), but their capacity for removing PhACs has not been previously assessed. 
Evaluating the benefits and services provided by natural wetlands, and employing these systems, 
requires an understanding of the system processes, as well as the responses of the systems to 
point and non-point source pollution.  For example, wetlands that are subject to pollution can 
become impaired as a result of inputs of wastewater, resulting in contamination of local wildlife 
(Barber et al., 2006; Pelley, 2006).   
Two recent publications have identified PhACs and other “down the drain” chemicals in 
surface waters in southeastern Louisiana. As reported by Boyd et al.  (2003) and Zhang et al. 
(2007), these compounds have been detected in the Mississippi River at New Orleans, in Lake 
Pontchartrain bordering New Orleans to the north, within the discharge from the Jefferson 
Parrish East WWTP and at the influent of the drinking water treatment plant. Of the 9 target 
analytes in the Boyd et al. (2003) study, two were detected (naproxen, triclosan) in WWTP 
effluent at ng L-1.  The Zhang et al. (2007) study found 10 of the 12 compounds of interest 
including; naproxen, ibuprofen, carbamazepine, clofibric acid, caffeine, triclosan, 
acetaminophen, bisphenol A, estrone, 17 α-ethinylestradiol and the natural estrogen, 17 β-
estradiol. It is possible that a range of other PhACs were also present in these samples. 
The goal of this study was to evaluate the removal of PhACs from untreated municipal 
wastewater in a lagoon-constructed wetland treatment system, and within a receiving forested 
wetland located in southeastern Louisiana.  The study objectives included: 1) determining 
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concentrations of PhACs loaded to and within the wastewater treatment system, 2) estimating the 
loading of PhACs to the forested wetland, and to the final receiving waters of Lake 
Pontchartrain, and 3) comparing reduction rates for PhACs in this natural treatment system to 
removal rates for more conventional wastewater treatment plants.  
2.2. Methods 
2.2.1. Study Area 
Mandeville, LA, USA is located on the north shore of Lake Pontchartrain.  The Mandeville 
WWTP is a nontraditional plant that treats the water in a constructed wetland, followed by a 
natural wetland. Untreated wastewater flows into three 61 x 183 x 3 m aerated lagoons in series, 
(Figure 2.1).  Each basin has a retention time of four and a half days, for a total of ~13 days of 
treatment. After retention in the aeration lagoons (basins), the water flows through a surface flow 
constructed wetland.  Water is evenly distributed across the width of the constructed wetland by 
percolation through a crushed gravel bed.  The water flows through the herbaceous marsh 
containing several wetland plant species, including Hydrocottle spp. and Phragmites australis.  
After a 1 day retention time in the constructed wetland, water is collected in two rock basins 
where 60% of the water is recycled back to the crushed gravel bed and pumped through a series 
of sprinklers to further aerate the wastewater.  The remaining 40% of water is pumped through 
an 8 x 1.2 m ultra-violet irradiation channel with 176 UV bulbs for disinfection. The water is 
then pumped out of a standpipe and into the adjacent forested wetland (i.e. Bayou Chinchuba) 
for polishing before discharge into Lake Pontchartrain (Figure 2.1).  The plant has historically 
discharged into Bayou Chinchuba (since 1989) at a rate of ~7200 m3 day-1. The retention time in 
the WWTP constructed system is ~14 days and Bayou Chinchuba flow varies by season due to 




Figure 2.1. Schematic of the Mandeville wastewater treatment plant and aerial image of the 
adjacent forested wetland (Bayou Chinchuba).  Arrows depict the direction of surface 
water flow from the plant, through the forested wetland and into Lake Pontchartrain. 
Water entering the WWTP immediately mixes with the roughly 33,500 m3 of water 
already in the first basin.  Water is then continuously mixed by fountains and aeration hose along 
the bottom of the basins.  Therefore, sewage entering the WWTP is quickly mixed and any 
pharmaceutical concentrations are normalized over the 4.5 day retention time within each basin. 
During the total 13 day retention time in the basins water is continuously mixed and 
concentrations should be homogenized within the basins.  Therefore variation, whether daily or 
weekly, of pharmaceutical compounds within the WWTP is minimized in this system. 
2.2.2. Field Sampling 
All sampling containers were pre-cleaned by washing with soap and water, rinsing with 
deionized water and then washing with acetone, followed by hexane.  The pre-cleaned 4 L amber 
bottles were used to collect water samples at various locations in the treatment plant and 
receiving wetland.   The sampling locations within the WWTP and constructed wetland (Figure 
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2.1) were selected in order to assess the removal capacity of the various treatment phases of the 
plant.  Samples were collected May 18, 2007 and chilled to 4 oC during transport to Louisiana 
State University for extraction.   
2.2.3. Analysis of PhACs 
All water samples were stored at 4oC and processed within 48 hours of collection. 
Samples (250 ml) were filtered with hexane-washed Whatman GF/F filters (Fisher Scientific) to 
remove all particulate matter and extracted using HLB solid phase extraction (SPE) cartridges 
purchased from Waters (Millford, Mass). The methods have been previously described for solid 
phase extraction of acidic drugs (Miao et al., 2002), neutral drugs (Zhao and Metcalfe, 2008), 
sulfonamide antibiotics (Miao et al., 2004) and beta-blocker drugs (Topp et al., 2008). Briefly, 
the pH of the sample was adjusted according to the class of compound to be extracted, and 
stable-isotope labeled surrogates were spiked into the samples at nominal concentrations of 50 
ng L-1 as internal standards. The four classes of PhACs were extracted by SPE using either HPLC 
Oasis or MCX cartridges. Extraction efficiencies for all analytes have previously been shown to 
exceed 75%. All samples were extracted in triplicate.   
 Extracts were shipped in chilled containers from Louisiana State University, Baton 
Rouge, Louisiana to Trent University, Ontario, Canada for analysis. The extracts were analyzed 
for the four classes of target compounds summarized in Table 2.1. Analysis was by liquid 
chromatography with tandem mass spectrometry (LC-MS/MS), conducted as described 
previously by Miao et al. (2002) for acidic drugs, Miao et al (2004) for sulfonamide antibiotics, 
Zhao and Metcalfe (2008) for neutral drugs, and Topp et al. (2008) for beta-blockers. The 
analytes were detected by monitoring in either negative or positive ion mode by multiple reaction 
monitoring (MRM). The acidic pharmaceuticals and beta-blockers were analyzed with a Quattro 
LC triple quadrupole mass spectrometer (Micromass, Manchester, U.K.) fitted with an 
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electrospray interface (ESI).  The neutral pharmaceuticals and sulfonamide antibiotics were 
analyzed with a QTrap mass spectrometer (MDS Sciex, Toronto, ON) equipped with an 
atmospheric pressure chemical ionization (APCI) ion source.  
Table 2.1. Target PhACs analyzed in samples of wastewater and water collected at the 
WWTP for Mandeville, LA, USA and the Bayou Chinchuba wetland, including data on the 
stable isotope surrogates used as internal standards and the limits of quantitation (LOQs). 
Class Compound Surrogate LOQ (µg/L) Use 
Neutrals Cotinine cotinine-D3 0.002 Nicotine metabolite 
Caffeine caffeine-13C3 0.002 Stimulant 
Carbamazepine carbamazepine-D10 0.003 Anti-epileptic, psychiatric drug 
Fluoxetine fluoxetine-D5 0.010 Psychiatric drug (Prozac) 
     
Beta Blockers Atenolol atenolol-D7 0.004 Hypertension 
Nadolol - 0.002 Blood pressure, Migraines 
Propranolol propranolol-d7 0.003 Hypertension 
Metoprolol metoprolol-d7 0.005 Hypertension 
Sotalol sotalol-d6 0.005 Hypertension, Arrhythmias 
     
Sulfonamides Sulfapyridine sulfamethazine-13C6 0.011 Antibiotic 
Sulfamethoxazole sulfamethoxazole-13C6 0.007 Antibiotic 
     
Acidics Acetaminophen acetaminophen-D3 0.017 Analgesic/anti-inflammatory 
Naproxen naproxen-13C1D3 0.007 Analgesic/anti-inflammatory 
Ibuprofen ibuprofen13C3 0.011 Analgesic/anti-inflammatory 
Gemfibrozil gemfibrozil-D6 0.008 Lipid Regulator 
 
 A series of external standards were prepared with different concentrations of the target 
analytes and fixed concentrations of stable isotope surrogates (Table 2.1). The concentrations of 
the analytes were determined by comparing the response to each analyte in the samples to the 
responses to each analyte in the external standards over the range of a calibration curve. These 
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response data were adjusted according to the relative ratios of the responses to the stable isotope 
surrogates in the sample and external standard. Note that this approach adjusts the quantitative 
data to compensate for efficiencies of extraction <100% and enhancement or inhibition of the 
signal due to the effects of the sample matrix.  Blanks were prepared by spiking Milli-Q water 
with labeled surrogates, and extracting and analyzing them as described previously. The limits of 
quantitation (LOQs), which are listed in Table 2.1 were estimated as the second lowest point in 
the linear calibration curve prepared by analysis of the external standards, for which the signal to 
noise ratio for the analytes in the native samples was >10. 
2.3. Results and Discussion 
Nearly all of the target compounds were detected in the untreated wastewater entering the 
treatment plant, with the exception of fluoxetine and propranolol (Table 2.2).  Nadolol, sotalol, 
and sulfapyridine were the only compounds that were detected in the untreated wastewater but 
not at the outfall into Lake Pontchartrain, indicating near complete aqueous concentration 
reduction.  The data indicate that the WWTP constructed wetland significantly decreased the 
concentrations of most target compounds, but not to below the LOQs.  The Bayou Chinchuba 
forested wetland was found to further reduce the concentrations of the target compounds. 
The total reduction rates of the compounds within the entire treatment system were 
greater than 90% for all compounds, except carbamazepine at 51% and sotalol at 82% (Table 
2.3). Several other PhACs (i.e. cotinine, caffeine, atenolol, nadolol, metoprolol, sulfapyridine, 
acetaminophen, naproxen, ibuprofen) were removed in amounts of 99% or greater by the entire 
system. A few compounds also showed reduction rates in the forested wetland between 20-31% 
(i.e. sulfapyridine, nadolol and gemfibrozil). The highest proportion of concentration reduction 
of the compounds from the aqueous phase occurred in the aeration basin of the WWTP (Figure 
2.2), which had a 13 day retention time.
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Table 2.2. Mean concentrations of target PhACs (µg L-1; n=3) at sampling locations at the WWTP for Mandeville, LA, USA and 
the Bayou Chinchuba wetland. Standard deviations represent error associated with extraction and analytical precision. 











Neutrals Cotinine 1.097 ± 0.060 0.030 ± 0.001 0.014 ± 0.001 0.019 ± 0.002 0.012 ± 0.004 0.015 ± 0.000 
Caffeine 25.567 ± 5.710 0.029 ± 0.006 0.033 ± 0.003 0.028 ± 0.006 0.065 ± 0.020 ND 
CBZ 0.057 ± 0.004 0.082 ± 0.006 0.087 ± 0.001 0.11 ± 0.007 0.028 ± 0.009 0.034 ± 0.001 
Fluoxetine ND ND ND ND ND ND 
        
Acidics Acetaminophen 39.300 ± 0.685 0.008 ± 0.001 0.015 ± 0.003 0.01 ± 0.001 ND ND 
Naproxen 10.418 ± 1.530 0.064 ± 0.009 0.193 ± 0.033 0.090 ± 0.010 0.031 ± 0.003 0.020 ± 0.004 
Ibuprofen 9.922 ± 1.177 0.039 ± 0.003 0.080 ± 0.009 0.038 ± 0.002 0.017 ± 0.001 0.013 ± 0.000 
Gemfibrozil 1.652 ± 0.112 0.645 ± 0.031 1.819 ± 0.281 0.600 ± 0.036 0.081 ± 0.003 0.061 ± 0.004 
        
Beta   
Blockers 
Atenolol 1.442 ± 0.102 0.284 ± 0.010 0.097 ± 0.009 0.099 ± 0.006 0.015 ± 0.001 0.020 ± 0.002 
Nadolol 0.030 ± 0.003 0.030 ± 0.001 0.007 ±0.00 0 0.007 ± 0.001 ND ND 
Propranolol ND ND ND ND ND ND 
Metoprolol 0.211 ± 0.032 0.025 ± 0.002 0.016 ± 0.001 0.017 ± 0.001 ND ND 
Sotalol 0.174 ± 0.019 0.148 ± 0.009 0.117 ± 0.005 0.121 ± 0.007 0.031 ± 0.019 0.022 ± 0.003 
        
Sulfonamides Sulfapyridine 0.068 ± 0.024 0.018 ± 0.008 0.016 ± 0.002 0.016 ± 0.003 ND ND 
SMX 4.090 ± 0.671 0.918 ± 0.463 0.309 ± 0.055 0.350 ± 0.024 0.328 ± 0.019 0.369 ± 0.124 
Standard deviations represent error associated with extraction and analytical precision. 






2.3.1. Acidic Compounds 
Three (acetaminophen, naproxen, Ibuprofen) of the four acidic compound concentrations 
were reduced below the limits of quantitation within the aeration basins, with gemfibrozil being 
the exception.  The removal of these compounds is similar to concentration reductions observed 
in previous studies for mechanized wastewater treatment (Ternes, 1998; Heberer et al., 2002; 
Bendz et al., 2005).  The initial gemfibrozil concentration entering the treatment system was 1.65 
µg L-1 and a 61% reduction was observed within the aeration basin.   
Table 2.3. Removal rates of pharmaceutically active compounds for the wastewater 
treatment plant at Mandeville, LA, USA and the receiving forested (Bayou Chinchuba) 
wetland.   






Neutrals Cotinine >99 0 >99 
Caffeine >99 0 >99 
Carbamazepine -53 105 51 
Fluoxetine ND ND ND 
     
Beta 
Blockers 
Atenolol >99 6 >99 
Nadolol 77 23 >99 
Propranolol ND ND ND 
Metoprolol 92 8 >99 
Sotalol 30 52 82 
     
Sulfonamides Sulfapyridine 76 24 >99 
Sulfamethoxazole 91 1 92 
     
Acidics Acetaminophen 100 0 >99 
Naproxen 99 1 >99 
Ibuprofen >99 0 >99 
Gemfibrozil 64 31 95 
ND = not detected at concentrations above the LOQ. 
2.3.2. Sulfonamides 
Sulfamethoxazole (78%) and sulfapyridine (74%) showed large reductions over initial 
concentrations of 4.090 µg L-1 and 0.068 µg L-1 within the aeration basins, respectively. The 
total concentration reduction by the WWTP and forested wetland for each compound was >99% 
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and 92% for sulfamethoxazole and sulfapyridine, respectively.  Both compound concentrations 
decreased throughout the Mandeville treatment plant, but remained constant after reaching the 
forested wetland. Previous studies have shown that concentrations of these compounds can 
increase during the wastewater treatment process (Bendz et al., 2005; Gobel et al., 2007).  One 
study found that sulfapyridine and sulfamethoxazole doubled in concentration during certain 
aspects of wastewater treatment (Gobel et al., 2007).  They hypothesized this increase may be 
due to the presence of metabolites that were transformed into salfapyridine and sulfamethoxazole 
during biological treatment.  Additionally, these compounds underwent ~96% reductions in 
concentrations with activated sludge treatment which is more inline with the removal rates 
observed in this study.   
2.3.3. Neutral Compounds 
The neutral compounds, cotinine and caffeine, were both nearly reduced to below 
detection within the aeration basins, while carbamazepine was detected at every step in the 
treatment process. Fluoxetine was not detected in the treatment system (Table 2.2).  There was 
an increase in carbamazepine concentration in the plant from 0.057 µg L-1 at the inflow to a max 
of 0.087 µg L-1 at the discharge into Bayou Chinchuba.  The carbamazepine concentration 
increased after the initial measurement at the sewage inflow and remained relatively constant 
until the measurement of the forested wetland midpoint, where the concentration dropped below 
the initial level. The concentration of carbamazepine continued to decrease and was only 0.028 
µg L-1 when discharged into Lake Pontchartrain, down from 0.058 µg L-1 at the inflow.  The 







CBZ= Carbamazepine; ACET=Acetaminophen; NPX=Naproxen; IBU=Ibuprofen; 
GEM=Gemfibrozil; ATEN=Atenolol; NAD=Nadolol; MET=Metoprolol; SOT=Sotalol; 
SMX=Sulfamethoxazole 
 
Figure 2.2. The mean concentrations (µg L-1) of the target pharmaceutically active 
compounds at the inflow into the aeration basins and at Cell 3 of the aeration basins of the 
Mandeville wastewater treatment plant, where there is a hydraulic retention time of ~13 
days.   
A possible explanation for this concentration increase within the plant is that there was a 
greater loading of the compound over a period of a couple of weeks prior to sampling.  However, 
this is unlikely as this drug is administered daily in either one or two doses up to 1600mg to treat 
chronic symptoms of seizures, ADD, schizophrenia, bipolar disorder and trigeminal neuralgia 
(USFDA, 2007).  An alternate explanation is carbamazepine is retained and persists in the 
aeration basins.  A similar trend was observed in the aeration basins during a November 2006 
sampling of the Mandeville WWTP (Unpublished data).  During this sampling, the 
carbamazepine concentration spiked in the aeration basins before dropping below the inflow 


















































irradiation has the ability to convert hydroxyl metabolites of carbamazepine to the parent 
compound or even modify the dissolved organic matrix in treated wastewater so that the analytes 
are released from the dissolved organic materials (Miao et al., 2005).   A similar trend was 
observed with synthetic musks treated with UV irradiation (Yang and Metcalfe, 2006).   
 The USEPA’s Estimation Program Interface (EPI) Suite estimates that carbamazepine 
removal in WWTP to be 2.96% of the total concentration, with 2.86% by sludge and 0.10% due 
to biodegradation (USEPA, 2007).  Previous research has shown that the removal rates of 
carbamazepine in WWTPs is greater than the EPI Suite estimate and ranges from less than 10% 
(Ternes, 1998; Heberer et al., 2002) up to 30% (Bendz et al., 2005; Miao et al., 2005).  The 
aqueous concentration  reduction observed for the Mandeville WWTP and forested wetland is at 
50%, indicating that this natural wastewater treatment system may be more effective at reducing 
concentrations of carbamazepine than conventional wastewater treatment. 
2.3.4. Beta Blockers 
Sotalol has the next lowest removal rate (behind carbamazepine). This drug compound 
was reduced by 82% compared to removal below the detection limits for the other beta blockers 
(atenolol, metoprolol).  Previous studies have shown that beta blockers are relatively persistent 
through the wastewater treatment process, with 30-80% removal of concentrations less than 1 
ppb in multiple WWTPs studied (Castiglioni et al., 2006; Maurer et al., 2007).  The removal 
rates from this study show that the Mandeville treatment system may be more effective at 
reducing the aqueous concentration of this class of pharmaceuticals from the aqueous phase.  
Other studies in conventional WWTPs indicated that atenolol decreased between 30-53% and 
metoprolol from 10-83% (Castiglioni et al., 2006; Maurer et al., 2007).  These values are also 




2.3.5. Compound Loading 
Estimates of the annual loadings of the PhAC compounds were based on a daily 
wastewater flow of ~7,600 m3 and on the mean concentrations detected in the samples.  The 
treatment system can potentially remove several hundred kg of PhACs annually, with caffeine 
(~70 kg) and acetaminophen (107 kg) being the largest contributors (Table 2.5).   
There could be competition between compounds for binding sites, where one compound 
may decrease or prevent sorption due to the presence of another (Li and Werth, 2001; Bonin and 
Simpson, 2007).  Competition could lead to an increase in downstream concentrations of the 
desorbed compound.  However, this may not be significant in vegetated wetland systems that 
receive nutrient rich, secondarily treated wastewater which can cause an increase in vegetation 
growth. The extra growth leads to increased accrual of organic matter which replenishes organic 
matter binding sites as new organic matter is deposited (Rybczyk et al., 2002).   
None of the PhACs enter Lake Pontchartrain in kilogram amounts annually, and 
concentrations are likely further diluted in this large lake (1,630 km2).  However, it has been 
shown that some of these compounds can have a detrimental effect on aquatic organisms 
exposed at ppb concentrations (Huggett et al., 2002; Flaherty and Dodson, 2005; Mimeault et al., 
2005; Lienert et al., 2007).  
2.3.6. Conventional vs Natural Wetlands 
Previous studies have shown that conventional wastewater treatment plants reduce the 
concentrations of PhACs in the aqueous phase, but the efficacy of removal varies widely with the 
drug and the treatment technology (Table 2.4).  However, the present study demonstrated that 
there was a high potential for reduction of PhACs in the constructed wetland within the 
Mandeville WWTP.  A major reason for the high degree of removal is that the Mandeville 
system functions with a hydraulic retention time (HRT) of approximately 14 days, whereas 
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conventional treatment plants have HRTs of 10-60 h, depending on the treatment technology.  
The extended treatment time allows for greater removal of microcontaminants, including PhACs, 
through processes of biodegradation, photolysis, etc. There was an additional concentration 
reduction between 0 and 50% in the forested wetland, although the mechanism (degradation, 
sorption, dilution) is unknown due to a lack of stream flow data in Bayou Chinchuba. 
2.3.7. Seasonal Removal 
When comparing the sampling event for this study with a previous sampling of the 
Mandeville WWTP from 11/20/2006 (Unpublished Data) there appears to be seasonal variation 
(12 to 300%) with regards to inflow concentrations of several compounds.  The most variation 
between seasons occurs with acidic (acetaminophen, naproxen, ibuprophen, gemfibrozil) and 
neutral (cotinine, caffeine, carbamazepine) compounds, while beta blockers and sulfonamides 
generally vary by less than 50%. With the exception of metoprolol and sulfamethoxazole, all 
compounds exhibited higher concentrations during November compared to May. 
While there may be variation with the inflow concentrations for the Mandeville WWTP, 
the percent removal within the WWTP is very similar for each sampling. Despite the varying 
inflow concentrations, the November ‘06 and May ‘07 samplings had 6, and 8 compounds, 
respectively, that exhibited >90% removal, while both had 10 compound with >75% removal.  
The percent concentration reduction difference between the two samplings was <18% for 10 of 
the 13 compounds detected, with gemfibrozil, carbamazepine and sotalol being the exceptions. 
It is important to note that these data only represent the PhAC compounds in the aqueous 
phase, since all samples were filtered prior to analysis to remove particulate material. However, 
previous studies have shown that PhACs adsorbed to suspended particulate material represents a 
small fraction of the total loads (Miao and Metcalfe, 2007). In addition, this sampling scheme 
provided only a snapshot of the removal of PhAC compounds in the wastewater stream, and did 
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Table 2.4. Percent removal and concentrations in treated wastewater reported in the literature for the target pharmaceutically 
active compounds in conventional wastewater treatment plants, compared to the removal rates of this study. 




µg/L Study  Wastewater Treatment Method  
Atenolol  99% 30-53%   Castiglioni et. al (2006) N/I 
50-80%   0.16  Bendz, D., N. A. Paxeus, et al. (2005) Clarification, Activated Sludge, P removal 
      
Caffeine  >99% 
>99%    0.19   Ternes, T., M. Bonerz, et al. (2001)   Aeration tank, P removal, Clarification  
99%    0.18   Heberer, T., K. Reddersen, et al. (2002)  N/I 
94%   0.22   Bendz, D., N. A. Paxeus, et al. (2005)   Clarification, Activated Sludge, P removal  
      
CBZ 51% 
7%   2.10   Ternes, T. A. (1998)   Clarification, Activated Sludge, P removal  
8%   1.63   Heberer, T., K. Reddersen, et al. (2002)  N/I 
30%   1.18   Bendz, D., N. A. Paxeus, et al. (2005)   Clarification, Activated Sludge, P removal  
      
Gemfibrozil  91% 69% 
  0.40   Ternes, T. A. (1998)   Clarification, Activated Sludge, P removal  
75%   0.18  Bendz, D., N. A. Paxeus, et al. (2005)   Clarification, Activated Sludge, P removal  
      
Ibuprofen  
99% 
90%   0.37   Ternes, T. A. (1998)   Clarification, Activated Sludge, P removal  
96%   0.15   Bendz, D., N. A. Paxeus, et al. (2005)   Clarification, Activated Sludge, P removal  
      
Metoprolol  >99% 30-65%   0.19   Bendz, D., N. A. Paxeus, et al. (2005) Clarification, Activated Sludge, P removal 
      
Naproxen  99% 66% 
  0.30   Ternes, T. A. (1998)   Clarification, Activated Sludge, P removal  
93%   0.25  Bendz, D., N. A. Paxeus, et al. (2005)   Clarification, Activated Sludge, P removal  
      
Sotalol 81.90% 25%   0.25   Maurer et. al (2007) N/I 
      
SMX 92% 0%   0.07   Bendz, D., N. A. Paxeus, et al. (2005)   Clarification, Activated Sludge, P removal  





Table 2.5. Loadings (kg year-1) of the target pharmaceutically active compounds to points within the Mandeville, LA, USA 
wastewater treatment plant and the Bayou Chinchuba receiving wetland. 



















Neutral Cotinine 2.99 0.04 0.03 2.95 0.00 2.95 
Caffeine 69.68 0.09 0.18 69.59 0.00 69.59 
CBZ 0.15 0.24 0.08 -0.09 0.16 0.08 
Fluoxetine ND ND ND ND ND ND 
        
Acidic Acetaminophen 107.11 0.03 0.00 107.08 0.00 107.11 
Naproxen 28.39 0.25 0.08 28.14 0.17 28.31 
Ibuprofen 27.04 0.11 0.05 26.94 0.06 27.00 
Gemfibrozil 4.50 1.66 0.22 2.85 1.44 4.28 
        
Beta   
Blockers 
Atenolol 3.93 0.27 0.04 3.66 0.23 3.89 
Nadolol 0.08 0.02 0.00 0.06 0.02 0.08 
Propranolol ND ND ND ND ND ND 
Metoprolol 0.57 0.05 0.00 0.53 0.05 0.57 
Sotalol 0.47 0.34 0.09 0.14 0.25 0.39 
        
Sulfonamides Sulfapyridine 0.19 0.04 0.00 0.14 0.04 0.19 
SMX 11.15 0.97 0.91 10.18 0.06 10.24 
Compound loading rates were calculated from the observed concentrations at various points in the treatment process, based on a flow rate 
of 7600 m3d-1.  
CBZ= Carbamazepine; SMX = Sulfamethoxazole; ND = not detected at concentrations above the LOQ. 
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not take into account temporal variations in PhAC inputs into the WWTP.  As mentioned 
previously, we believe that daily and weekly concentration variations are normalized due to 
basin retention times.  Also, national prescription patterns (USFDA, 2007) show that for many of 
the compounds monitored (excluding the sulfonamide antibiotics, ibuprofen, naproxen, and 
acetaminophen), the remaining drugs are prescribed for long term usage (e.g. carbamazepine, 
beta-blockers, gemfibrozil, fluoxetine) or otherwise show homogeneous levels of consumption 
(e.g. caffeine, cotinine). Future work will focus on the temporal and seasonal variability of PhAC 
concentrations in wastewater and removal within the wetland system. 
2.4. Conclusions 
Results demonstrate that a wastewater treatment system consisting of earthen lagoons and 
a constructed wetland such as those used in the Mandeville WWTP show a greater reduction in 
compound concentration than previous studies demonstrated for conventional plants. Further 
polishing in a natural forested wetland produced removal rates for PhACs that averaged 96% for 
the entire system. There is variation with inflow concentration in the WWTP, but these 
concentrations are normalized on a daily to weekly basis by mixing within the aeration basins. 
Seasonal variability may be more pronounced, with greater concentrations entering the facility 
during colder months.  However, removal rates for both November and May were similar. These 
removal rates are equal or greater than published removal rates in conventional wastewater 
treatment plants. In particular, carbamazepine and sotalol appear to be more persistent in 
conventional WWTPs than in the Mandeville wastewater treatment system.  The higher removal 
rates may be due to a longer HRT in the constructed and natural treatment system.  The entire 
system is capable of removing several kilograms per year of PhACs from wastewater, 
significantly reducing the annual loadings of these compounds to Lake Pontchartrain.   
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CHAPTER 3: PHARMACEUTICAL ANALYSIS FOR ENVIRONMENTAL 
SAMPLES: INDIVIDUAL AND SIMULTANEOUS DETERMINATION OF 
CIPROFLOXACIN, OFLOXACIN AND NORFLOXACIN USING AN 





Pharmaceuticals, including fluoroquinolone antibiotics, have been detected in surface 
waters around the world (Golet et al., 2001; Nakata et al., 2005; Batt et al., 2006; Batt et al., 
2007; Conkle et al., 2008).  The fate of these compounds in the environment needs further 
investigation, specifically pertaining to sorption, desorption, transport, and biotic and abiotic 
degradation (White et al., 2006). 
 
 
Figure 3.1. Structure of the three compounds for which analytical methods were developed. 
Methods have been developed for the determination of ofloxacin (OFL), norfloxacin 
(NOR) and ciprofloxacin (CIP) in sewage using an HPLC (Carlucci, 1998; Golet et al., 2001; 
Samanidou et al., 2003; Lee et al., 2007a). However, these methods require solid phase 
extraction (SPE) and have retention times in excess of 10 minutes.  Laboratory scale experiments 
aimed at elucidating removal mechanisms yield large numbers of samples (ranging from 100s to 
1000s), which, when combined with long preparation and analysis times makes such approaches 
impractical for most laboratories.  The motivation behind the presented study was to reduce the 
time required to analyze fluoroquinolone antibiotic as well as developing a method which is 
                                                          
2 Re-print with permission from Taylor & Francis, Appendix B 
Ciprofloxacin Norfloxacin Ofloxacin 
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effective for complex environmental matrices while, at the same time, having detection limits 
appropriate for environmental analysis. All three of these compounds have similar structures and 
properties, which can make separation of each compound more challenging in the presence of 
the others.       
Therefore, the goal of this research was to develop a method for individual and 
simultaneous analysis of CIP, NOR and OFL (Figure 3.1) using standard HPLC equipment (with 
UV and fluorescence detection), 1) with short retention times, 2) that eliminates the need for 




CIP, NOR and OFL (HPLC grade) were obtained from Sigma-Aldrich (St. Louis, MO) in 
powder form.  HPLC grad solvents, acetonitrile and water were purchased from Mallinckrodt 
chemicals. Methanol (HPLC grade), glacial acetic acid (biochemical grade, 99.8%) and sodium 
azide (99%) were obtained from Acros Organics. Sodium acetate (anhydrous, 99.7%) and 
calcium chloride (anhydrous, 96.0%) were purchased from Fisher Scientific and Sigma-Aldrich 
respectively. All solvents used were HPLC grade. Trimethylammonium phosphate buffer 
solution (pH = 3), as well as citric acid and sodium citrate monobasic (both anhydrous, ultra 
grade ≥99.5%) were supplied by Fluka Bio Chemika. An 18 mΩ sensitivity water filter with a 
0.1 µm filtering device (Modular Water systems, United States Filter Corporation) was used to 
treat all water used in the stock, standard electrolyte solution and sample solution preparation. 
3.2.2. UV and Fluorescence 
UV-vis (on a Cary 50Bio, Palo Alto, CA) and fluorescence (on a Fluorolog, Horiba Jobin 
Yvon, Edison, NJ) characterization was carried out on all three antibiotics.  The UV-vis and 
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fluorescence data yielded absorbance and emission maxima of 272, 273 and 289 nm and 421, 
414 and 458 nm for CIP, NOR, and OFL, respectively.  CIP and NOR have similar absorbance 
and emission spectra, while OFL has a higher range.  
3.2.3. Chromatography 
The liquid chromatographic system used in this study consisted of an Agilent 1100 (Santa 
Clara, CA). This LC instrument is equipped with the following parts: solvent degasser 
(G1379A), quaternary pump (G1311A), automatic liquid sampler (G1329A), temperature 
controlled column compartment (G1316A), DAD detector (G1315B) and fluorescence detector 
(G1321A).  The instrument was fitted with a Zorbax (Santa Clara, CA) eclipse XDB C18 (4.6 
mm x 150mm x 5μm) column, and a Phenomenex (Torrance, CA) C18 guard column (4.0 mm x 
3.0 mm x 5 µm). 
For the analysis of CIP, NOR and OFL as separate components, the mobile phase 
consisted of sodium acetate (pH 3), acetonitrile (ACN) and triethylamoniumphosphate (TEA) 
(10 mM). The TEA solution was added to solutions to minimize peak tailing (Snider et al., 1997; 
Zendelovska and Stafilov, 2005).   A 60:40 v:v ratio sodium acetate to ACN was used for CIP 
and NOR, while a 70:30 ratio was used for OFL.  For simultaneous analysis of all three 
fluoroquinolones, an aqueous citric acid buffer (pH 2.5), ACN, methanol (MeOH) in a 82/8/10 
v/v ratio mobile phase was utilized (a modified adaptation from Canada-Canada et al. [9]).   A 
column temperature of 35°C, a flow rate of 1 mL min-1 and an injection volume of 20 µL were 
used.  For UV-vis detection, a wavelength of 280 nm and λex/λem, of 280/450nm was found 
optimal for fluorescence detection.  All methods were run in isocratic mode and used a direct 
injection of aqueous samples without prior sample pretreatment.  All samples were injected into 




3.2.4. Preparation of Standard Solutions 
Stock solutions with concentrations of 80 mg L-1 were prepared in triplicate. In addition, 
each stock solution contained 100 mg L-1 sodium azide (to remove possible biological 
components) and 0.01 M CaCl2 (to mimic the ionic strength of environmental samples). Stock 
solutions were used to create a 9-point standard curve for each fluoroquinolone. The standard 
solution was subsequently diluted with water to yield concentrations spanning three orders of 
magnitude from 0.05 to 80 mg L-1.  The 80 mg L-1 stock solutions were also used to create the 
10-point standard curve for the simultaneous method, with standard solution concentrations 
ranging from 0.04 to 20 mg L-1. All standards were prepared from the triplicate stock solutions 
prior to its use and each standard was injected into the instrument in triplicate. When standards 
and stock solution were not in use they were stored at 4 oC in darkness. Peak area was used for 
determination of compound concentrations, not height. 
Table 3.1. Parameters from the Bayou Castine wetland soil used for environmental method 
application. All standards used in method development were prepared in triplicate and 
injected in triplicate. (± values represent standard deviation) 
Parameter Value 
Cation Ex Capacity (cmolc kg-1)‡ 19.8 ± 0.8 
Moisture content (%)  65 ± 0.0  
pH  6.9 ± 0.2  
Organic matter (%) †€ 18.6 ± 1.0  
Total Carbon (g kg-1)¥€ 88.4 ± 3.3 
Total Phosphorus (mg kg-1)€ 474.2 ± 15.8 
Total Nitrogen (g kg-1)¥€ 6.2 ± 0.2 
Clay (%)  31.3 
‡ (Sumner and Miller, 1996) 
† Loss on ignition 
€ Dry soil basis 





3.2.5. Method Validation with a Wetland Soil 
These methods were tested using an environmental matrix; soil from a local wetland 
classified as an Arat Silty Clay Loam, which is a fine silty, siliceous, non-acid, thermic Typic 
Hydraquent (Trahan et al., 1990). This particular soil was chosen because it is the same class as a 
soil in a nearby treatment wetland that receives treated wastewater containing pharmaceuticals 
and its parameters are shown in Table 3.1.  Woody and root materials were removed and the soil 
was homogenized and refrigerated at 4 oC prior to experimental analysis. A 20 mL aliquot of 
solution containing 5 mg L-1 of CIP, NOR, and/or OFL (the remainder of the solution 
composition was identical to that of the standard solutions) was added to glass vials containing 
50 mg of field moist soil.  Blank vials containing only the antibiotic solution were prepared to 
account for sorption to the glass scintillation vials, which is essential for mass balance 
calculations. Four replicates of each treatment were prepared and shaken for 5 days.  At the end 
of the incubation, samples were centrifuged and 2 mL was extracted for analysis using the 
methods presented in this study. Blanks containing only the spiked solution demonstrated that 
there was little if any sorption to the glass vials. 
3.3. Results and Discussion 
3.3.1. Overall Chromatographic Performance 
In recent years the presence of pharmaceuticals in the environment has been a topic of 
growing concern.  While there is a need for data obtained in the field with regards to compound 
identification, transport and fate, controlled lab studies can provide a baseline for understanding 
compound interactions in the environment. We developed two methods for the analysis of three 
fluoroquinolone compounds using an HPLC with UV and fluorescence detection that improve 
upon previous methods by decreasing analysis times. 
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For the methods developed in this work, the retention times for analysis of individual 
compounds (1.5-1.7 min) are significantly shorter than those obtained with the multiple 
compound detection method (6.5-8.0 min) (Table 3.2). A short retention time for individual 
compound detection is important when performing laboratory studies that require hundreds of 
samples, such as sorption and desorption experiments.  However, when analyzing compounds 
simultaneously there is a significant increase in retention time.  The method recently developed 
by Canada-Canada et al. (2007) demonstrated retention times of 7.8-9.7 min for the same 
compounds when analyzed simultaneously along with twelve other fluoroquinolone compounds. 
Therefore, when only analyzing these three compounds, the two methods presented herein 
provide at a minimum 1) 4.5-6.4 times shorter retention times for individual compounds and 2) 
14-17 % shorter retention times for simultaneous compound detection over previously published 
methods (Golet et al., 2001; Canada-Canada et al., 2007; Lee et al., 2007a). 
All UV standard curves achieved >0.995 R2 value for concentrations ranging from 0.055 
(CIP, NOR) or 0.11 (OFL) to 80 mg L-1 for individual compound detection. UV detection was 
effective over the entire range tested for individual compounds.  However fluorescence detection 
of individual compound was only linear at the lower end of the range tested (~0.06 to 1.5 mg L-
1). This indicates that UV analysis is best when either unsure of compound concentration or the 
known range varies from µg L-1 to mg L-1. 
For the simultaneous method, the standard curve was linear up to the concentration of 20 
mg L-1 for both UV and fluorescence.  The R2 values was near 1.0 for UV analysis during 
simultaneous detection and >0.995 for CIP and OFL fluorescence. However, the NOR R2 was 




Table 3.2. Method development calibration curves of CIP, NOR & OFL using UV and fluorescence. (± values represent standard 
deviation) 
UV 
Method   
Retention Time 
(min) Slope Intercept R²  Range Tested (mg L-1) LOQ (mg L-1)†  
Single 
CIP  1.520 ± 0.000 125.63 ± 1.93 28.55 ± 20.59 0.999 ± 0.000 0.0570 ± 0.008 - 80.833 ± 0.684 0.024 
NOR  1.511 ± 0.000 124.61 ± 0.67 19.4 ± 9.68 0.999 ± 0.000 0.0597 ± 0.004 - 79.200 ± 1.266 0.033 
OFL  1.704 ± 0.000 52.86 ± 0.42 9.53 ± 2.65 0.999 ± 0.000 0.1093 ± 0.025 - 79.933 ± 0.133 0.017 
Triple 
CIP  8.041 ± 0.077 91.55 ± 0.49 -7.29 ± 0.45 1.000 ± 0.000 0.1637 ± 0.123 - 20.342 ± 0.158 0.037 
NOR  7.000 ± 0.063 88.41 ± 1.34 -7.32 ± 1.63 1.000 ± 0.000 0.1567 ± 0.112 - 19.742 ± 0.283 0.035 
OFL  6.509 ± 0.057  35.59 ± 0.16 -2.9 ± 0.19 1.000 ± 0.000 0.0533 ± 0.003 - 19.950 ± 0.000 0.078 
        Fluorescence 
Method   
Retention Time 
(min) Slope Intercept R²  Range Tested (mg L-1) LOQ (mg L-1)†  
Single 
CIP  1.552 ± 0.001 590.99 ± 22.27 -6.92 ± 3.91 0.999 ± 0.000 0.0653 ± 0.001 - 1.362 ± 0.280 0.065 
NOR  1.542 ± 0.000 613.8 ± 16.41 5.81 ± 1.76 0.997 ± 0.001 0.0597 ± 0.004 - 0.931 ± 0.357 0.030 
OFL  1.737 ± 0.000 432.09 ± 15.24 9.83 ± 2.28 0.997 ± 0.001 0.0827 ± 0.003 - 1.599 ± 0.003 0.024 
Triple 
CIP  8.088 ± 0.075 350.97 ± 3.35 19.8 ± 4.87 0.999 ± 0.000 0.1637 ± 0.123 - 20.342 ± 0.158 0.011 
NOR  7.026 ± 0.063 356.53 ± 4.6 81.68 ± 4.62 0.989 ± 0.000 0.1533 ± 0.113 - 19.742 ± 0.283 0.019 
OFL  6.533 ± 0.057 61.47 ± 0.30 -3.65 ± 0.40 1.000 ± 0.000 0.0533 ± 0.003 - 19.950 ± 0.000 0.061 







There did not appear to be any degradation of the compounds, as indicated by the absence 
of significant peaks other than the target compounds during both sample and standard analysis 
(Figures 3.2 & 3.3). It should be noted that both methods are isocratic in nature, and hence, can 
be run on an HPLC instrument with a single channel pump.  In comparison, the method 
developed 
by Canada-Canada et al. (2009) requires, at a minimum, a three channel pump.  In addition, it 
was found that the mobile phase is required to be at a pH below 3 in order to resolve NOR and 
OFL satisfactorily. All standard samples were prepared in triplicate and injected into the HPLC 
in triplicate to account for variation in standard preparation and the detector. There is a small 
signal between 1.1-1.6 minutes that was attributed to contamination of the HPLC water that was 
detected by UV analysis (Figure 3.2).  This signal appeared during fluorescence analysis as well, 
but with a much lower response. This HPLC water signal was most noticeable during UV 
analysis when compound concentrations were low and was observed during environmental 
application (Figure 3.3). 
3.3.2. Buffer Solutions 
The use of sodium acetate buffer (pH = 3) in the individual analysis of antibiotics or 
citrate buffer (pH = 2.5) in the simultaneous separation has a two-fold purpose. The mobile 
phase pH is below the pKa’s of the fluoroquinolones and prevents ionization of the molecules. 
For example, CIP has the following reported pKa’s: carboxylic group (5.85 – 6.35), amino (8.24 
– 8.95) and the other two N groups (5.05, 3.64) (De Witte et al., 2007). In addition the use of low 
pH (2.0 < pH < 2.5) minimizes the presence of free unprotonated silanol groups of silica-based 
columns. Previous methods employed phosphoric acid (Zendelovska and Stafilov, 2005), citric 







Figure 3.2. UV and Fluorescence signals of individual and simultaneous compound 





















































































































































































Figure 3.3. UV and fluorescence signals of individual compound detection with a wetland 
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et al., 2007a). Moreover, triethylammonium from TEAP exchanges with less strongly retained 
ions such as sodium cations, thereby reducing the amount of free ionized silanol groups and  
suppressing the access of fluoroquinolones to residual silanols (Snider et al., 1997; Zendelovska 
and Stafilov, 2005). All of the above reasons result in peak shape improvement and decrease in 
retention times for the fluoroquinolones tested. 
3.3.3. Mobile Phase Ratios 
For individual compound analysis a 60:40 mobile phase consisting of sodium acetate and 
ACN was used for CIP and NOR while a 70:30 ratio was used for OFL. When all three 
compounds are run with the same amount of ACN in the mobile phase, the first fluoroquinolone 
to elute is OFL. If a 60:40 (A/B) mobile phase for ofloxacin is used, a potential problem arises 
especially at very low ppb level detection, where ofloxacin may completely overlap with early 
eluters from the matrix solution. Therefore, the 70:30 ratio is needed for proper OFL separation. 
3.3.4. Simultaneous Method 
The ability to simultaneously detect fluoroquinolone compounds allows us to analyze 
samples that are representative of environmental conditions, where multiple compounds may be 
present in a water sample. The single methods developed for individual compounds would not 
allow for simultaneous detection of all three compounds because CIP and NOR have similar 
retention times. The method for simultaneous detection was developed to ensure that there was 
separation between CIP and NOR.  
This simultaneous method provides a closer examination of pharmaceutical and soil 
interaction in lab microcosm experiments. The method performed well when used to analyze the 
three compounds in the presence of a wetland soil. There was no interference observed during 
simultaneous method sample analysis (Figure 3.3). 
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Table 3.3. UV and Fluorescence results obtained from method application on Bayou Castine soils that validate the application 
of these methods on environmental matrices. Each compound demonstrated high sorption to the soil, with low concentrations 










Conc. In soil 
(g kg-1) 
Conc. In solution 
(mg L-1) % in Solution % on Soil  
UV Retention 
Time 
CIP 97.99 ± 0.08 93.07 ± 2.55 4.92 ± 2.53 4.06 ± 0.08 0.25 ± 0.13 5.02 ± 2.58 94.98 ± 2.58 1.50 ± 0.00 
NOR 98.39 ± 0.08 91.97 ± 1.21 6.42 ± 1.21 4.01 ± 0.20 0.33 ± 0.06 6.53 ± 1.23 93.47 ± 1.23 1.50 ± 0.00 
OFL 98.34 ± 0.08 87.3 ± 2.61 11.04 ± 2.55 3.81 ± 0.11 0.56 ± 0.13 11.23 ± 2.59 88.77 ± 2.59 1.67 ± 0.00 








Conc. In soil 
(g kg-1) 
Conc. In solution 
(mg L-1) % in Solution % on Soil  
Fluorescence 
Retention time 
CIP 97.99 ± 0.08 92.34 ± 2.85 5.65 ± 2.83 4.03 ± 0.07 0.29 ± 0.14 5.77 ± 2.89 94.23 ± 2.89 1.54 ± 0 
NOR 98.39 ± 0.08 89.47 ± 1.42 8.92 ± 1.34 3.90 ± 0.15 0.45 ± 0.07 9.07 ± 1.37 90.93 ± 1.37 1.54 ± 0 
OFL 98.34 ± 0.08 88.36 ± 2.47 9.98 ± 2.41 3.85 ± 0.11 0.51 ± 0.12 10.15 ± 2.45 89.85 ± 2.45 1.70 ± 0 
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3.3.5. Analysis of Soil Samples 
Neither interference nor degradation was observed during the soil sample analysis, as indicated 
by the absence of significant peaks other than the target compounds, a sodium azide peak at ~ 2 
minutes and the low background signal (Figure 3.3).  Blanks with soil and electrolyte solution 
showed no additional peaks associated with soil for either method during both UV and 
fluorescence detection (Figure 3.3). A mass balance was calculated, taking into account any 
compound sorbed to the surface of the vial, to determine the sorption rates of each compound 
onto the soil. Peak retention times for the environmental matrix samples were within 2.5% of 
those observed for the standards (Table 3.3 and Figure 3.3). Both methods produced 
corresponding results that showed high sorption to the wetland soil. For both UV and 
Fluorescence at 5 mg L-1, the three compounds exhibited high sorption to the wetland soil, with 
both CIP and NOR sorbing >90% and OFL ~88% (Table 3.3).  
3.4. Conclusions 
In comparison to previously published methods, the methods developed in this work 1) 
allow for faster analytical throughput , with retention times that are 4.5-6.4 times shorter for 
individual compounds and 14-17% shorter for simultaneous detection of three antimicrobial 
pharmaceuticals (CIP, NOR and OFL), 2) remove the necessity of time consuming solid phase 
extraction if detection down to the low part per billion is desired, and 3) require minimal HPLC 
hardware, especially in the isocratic mode.   
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CHAPTER 4: SORPTION, DESORPTION AND COMPETITION 
BETWEEN THREE FLUOROQUINOLONE ANTIBIOTICS IN A 




Fluoroquinolones (FQs) are used in human, veterinary and agricultural applications with 
CIP, OFL and NOR being three of the most widely used (Pico and Andreu, 2007).  
Fluoroquinolones have been detected at levels up to 0.12 and 0.33 µg L-1 in surface water and 
wastewater effluent, respectively (Kolpin et al., 2002).  This raises concerns about the potential 
ecotoxicity of these compounds, individually or as a mixture (Isidori et al., 2005; Robinson et al., 
2005; Lee et al., 2007b) and the evolution of resistance to frontline antibiotics bacterial strains 
(Waters and Davies, 1997; Kern, 2007; Yamane et al., 2007).  Fluoroquinolones enter the 
environment by passing through wastewater treatment plants (WWTP) and the application of 
WWTP sludges to soil (Golet et al., 2003; Pico and Andreu, 2007). Once in the environment, 
FQs may sorb to solid matrices, such as soils and sediments, and there may be competition 
among multiple pharmaceutical compounds for preferred soil binding sites (Li and Werth, 2001; 
Bonin and Simpson, 2007). 
Wastewater treatment facilities discharge into adjacent wetlands for tertiary treatment of 
the wastewater to reduce nutrient concentrations to background levels before they enter larger 
surface water bodies and alter ecosystem dynamics (Verhoeven and Meuleman, 1999; Day et al., 
2006). Pharmaceutically active compounds (PhAC) are consistently found in WWTP effluent 
and, in some areas, WWTP effluent is discharged into wetlands for additional treatment 
(Metcalfe et al., 2003; Watkinson et al., 2007; Conkle et al., 2008). Recent studies have shown 
that surface and subsurface flow wetlands are effective at reducing PhAC concentrations 
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(Matamoros and Bayona, 2006; Waltman et al., 2006; White et al., 2006; Conkle et al., 2008).  
More research is required to address the chemical interactions, fluxes and system mitigation 
within these wetlands, with fluoroquinolone antibiotics being the focus of this study.  
The goal of this study was to examine the sorption and desorption behavior of three 
related and highly used compounds,  CIP, NOR, and OFL to a wetland soil and specifically we 
sought to 1) determine the sorption and 2) desorption of compounds within a wetland soil, and 3) 
assess competition among these similar antibiotics for binding sites on the soil.    
4.2. Methods 
4.2.1. Stock and Spike Solutions 
Bayou Castine (15R 784949 E, 3361530 N) wetland soils were chosen for this study as 1) 
the Mandeville, LA wastewater treatment plants continuously discharges trace amount of 
numerous PhACs into the adjacent Bayou Chinchuba and Bayou Castine serves as the control 
wetland for Bayou Chinchuba research (Conkle et al., 2008), 2) Bayous Chinchuba and Castine 
are classified as Arat Silty Clay Loam, which is a fine silty, siliceous, non-acid, thermic Typic 
Hydraquent (Trahan et al., 1990).  The surface soil (0-10) was collected by pushcore, 
homogenized and stored at 4 °C.  Soil characterization included total and extractable metals 
(DeLaune et al., 2008) and total carbon, total nitrogen and organic matter (White and Reddy, 
2000) and the data are reported in Tables 4.1 and 4.2.  CIP, NOR and OFL were obtained from 
Sigma-Aldrich (St. Louis, MO) and used to create an aqueous stock solution of 100 mg L-1, from 
which a 6-point standard curve and spike concentrations were created.  All solutions contained 
0.01 M CaCl2 and 100 ppm sodium azide (NaN3). Sodium azide is added to samples, as a biocide 
to prevent microbial degradation of compounds.  Antibiotic compound spike levels are above 
environmentally relevant concentrations.  However, we set out to simulate longer-term loading 
where a wastewater treatment plant discharges for example, 7.5 million liters daily with 2 µg L-1 
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of a compound, which roughly equals 15 g into the environment. Therefore, these soils may be 
loaded with much larger amounts of the compound than just a few µg and the sorption 
incubation concentrations were increased to mimic longer-term soil exposure amounts. 




Al 11.6 ± 8.2 29284.3 ± 478.6 
Ca 1765.4 ± 20.6 1830.9 ± 19.5 
Fe 170.9 ± 78.4 11072.9 ± 158.2 
K  202.6 ± 20.1 1527.5 ± 53.4 
Mg 1117.1 ± 18 2155.2 ± 31.2 
Na 499.6 ± 17.9 502.8 ± 8.8 
Metal analysis was performed using an ICP in accordance with DeLaune et al. 2008 
Table 4.2 Bayou Castine soil chemical properties 
Parameter Value 
Cation Ex Capacity (cmolc kg-1)‡ 19.8 ± 0.8 
Moisture content (%)  65 ± 0.0  
pH  6.8 ± 0.2  
Organic matter (%) †€ 18.5 ± 1.0  
Total Carbon (g kg-1)¥€ 88.3 ± 3.3 
Total Phosphorus (mg kg-1)€ 474.1 ± 15.8 
Total Nitrogen (g kg-1)¥€ 6.1 ± 0.2 
Clay (%)  31.3 
‡ (Sumner and Miller, 1996) 
† Loss on ignition 
€ Dry soil basis 
¥ (White and Reddy, 2000) 
4.2.2. Sorption and Desorption 
The Organization for Economic Cooperation and Development (OECD) method 106, 
adsorption – desorption batch equilibrium method was followed (European Union, 2000).  
However, samples were incubated longer than the suggested 24 hrs in the method to allow for 
pseudo-equilibrium to be reached. Sodium azide was also added to soils to prevent microbial 
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degradation of test compounds. The soil was homogenized and all woody debris and plant 
materials were removed. Samples were prepared with 100 mg (dry basis) field moist soil in glass 
scintillation vials in quadruplicate and incubated at 24 °C while being orbitally shaken at 150 
rpm for 3-5 days in the dark. Immediately after incubation, samples were centrifuged at 3000 
rpm (604 x g) for 15 minutes and the supernatant was extracted. Desorption incubations were run 
using the same sorption samples.  For desorption, most of the remaining solution in the vials was 
removed and the amount of solution remaining was determined using mass balance. Then, the 
original volume of matrix solution was then added to each vial.  From the concentration of the 
solution at pseudo-equilibrium, and knowing the volume remaining in the vial prior to matrix 
solution addition, the concentration of the antibiotic concentration at desorption time 0 (zero) 
was determined. The samples were then incubated, extracted and analyzed the same manner as 
the sorption experiment.  
Table 4.3. Instrument analytical parameters for measuring the three analytes of interest 
both individually and simultaneously. 




Ofloxacina 7.027 32.264 -7.0027 0.9997 97.8 
Norfloxacina 7.552 61.163 -9.5596 0.9998 55.7 
Ciprofloxacina 8.714 80.803 -13.623 0.9998 49.3 
Ofloxacinb 1.672 52.302 3.8022 0.9999 84.3 
Norfloxacinb 1.514 131.21 -0.403 0.9999 58.8 
Ciprofloxacinb 1.513 167.49 -0.403 0.9999 65.3 
a simultaneous detection of fluoroquinolones using DAD 280 nm 
b individual detection of fluoroquinolone using DAD 280 nm 
1LOQ- limit of quantitation (S/N=10) 
 
All samples were analyzed following Conkle et al (2009) using an Agilent 1100 (Santa 
Clara, CA) series HPLC with UV and fluorescence detectors fitted with a Zorbax eclipse XDB 
C18 (4.6 x 150 mm x 5 μm) column. Only UV detection was used during this experiment.  For 
NOR and CIP analysis, a 60:40 mobile phase consisting of acetate buffer (pH=3) with 
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triethylammoniumphosphate buffer (TEA); acetonitrile (ACN) was used. For OFL analysis, the 
mobile phase remained the same but the ratio was adjusted to 70:30. The simultaneous detection 
method for all 3 FQs used a mobile phase solvent ratio of 82:8:10 with citric acid buffer (pH 
2.5): ACN: methanol.  Analytical parameters are provided in Table 4.3 (Conkle et al., 2009).  
4.2.3. Data Analysis 
Percent and total amount sorbed were determined using the OECD guidelines. The 
amount sorbed (𝐶𝐶𝑠𝑠𝑎𝑎𝑎𝑎𝑠𝑠 ) (Equation 4.1) was calculated using mass balance between the compound 
concentration initially in solution (𝐶𝐶0) and the amount remaining in solution at equilibrium 
(𝐶𝐶𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑠𝑠 ), which accounts for sorption to the glass vials.  The calculations also account for the 
initial solution volume (𝑉𝑉0) and dry soil mass (𝑚𝑚𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 ). 
Equation 4.1: Csads (eq) =  
�C0−Caqads (eq )� × V0
msoil
  (μg g−1) 
The sorption distribution coefficient (𝐾𝐾𝑎𝑎) (Equation 4.2) for a particular concentration 
was calculated by dividing the 𝐶𝐶𝑠𝑠𝑎𝑎𝑎𝑎𝑠𝑠  at equilibrium by the concentration in solution (𝐶𝐶𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑠𝑠 ) at 
equilibrium. 
Equation 4.2:  Kd =  
Csads (eq )
Caqads (eq )
  ( cm3 g−1) 
Freundlich Isotherms were determined by graphing the log of the compound 
concentration in soil on the Y-axis and the log of the aqueous compound concentration on the X-
axis.  The equation of the best fit line was determined and the y-intercept is the Freundlich (KF) 
coefficient, while the 1/slope is the regression coefficient.  It should be noted that although N ≠ 
1, the use of KD to compare the sorption affinity of these individual FQs to its mixture may be 
allowed due to similarity in N, or by the use of the equation KD= KFCe (N-1) (Carmo et al., 2000).  
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 A one-way ANOVA was run using SPSS 15 (SPSS Inc.) to determine the difference 
between the KD means for sorption and desorption of 60 ppm, 20 ppm and competition (20 ppm 
each of CIP, NOR, OFL in solution). If the homogeneity of variance (HOV) was >0.05, a Latin 
Square Design (LSD) was used to determine differences between the KD means.  If the HOV was 
<0.05, the Dunnett’s T3 test was used.  
Electrostatic potential surface models were generated using Sybyl 8.0 (Tripos 
International, St. Louis, MO). These models were used to examine the charged surface of each of 
the fluoroquinolone antibiotics to aid in understanding differences in sorption and desorption for 
each compound.  
 
Figure 4.1. Competition analysis diagram demonstrating a conceptual framework for the 
competition comparisons. 
4.2.4. Simultaneous Compound Analysis 
Sorption and desorption of soil samples spiked with 20 and 60 ppm FQs were examined 
along with an additional set of samples spiked with a solution containing 20 ppm of each 
compound, for a total of 60 ppm of antibiotics in the mixture.  The 60 ppm multiple compound 
samples were used to determine effects on sorption or desorption due to competition between 
compounds for binding sites.  Sorption and desorption KD values at 20 and 60 ppm for CIP, 
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NOR and OFL were compared to determine any difference in sorption potential at these two 
concentration levels.  The individual 20 and 60 ppm KD values were then compared to the KD 
values determined for multiple compound analysis, and a comparative matrix is provided in 
Figure 4.1.  
Table 4.4. Sorption kinetics data for 20 ppm solutions with mass and percent sorbed. 
Kinetics at 20 ppm 
Hours g kg
-1 Dry Soil % Sorbed 
CIP NOR OFL CIP NOR OFL 
8 4.49 ± 0.57 3.67 ± 0.92 3.71 ± 0.16 34 ±  4 34 ± 9 32 ± 2 
12 5.83 ± 1.07 5.29 ± 0.97 4.99 ± 0.73 44 ± 7 47 ± 9 43 ± 7 
16 6.31 ± 1.44 7.33 ± 0.54 5.65 ± 0.53 49 ± 11 63 ± 4 49 ± 5 
20 8.21 ± 0.90 7.11 ± 0.38 7.75 ± 0.68 62 ± 7 62 ± 2 65 ± 6 
24 7.39 ± 0.54 6.33 ± 2.50 7.17 ± 0.91 58 ± 4 56 ± 22 62 ± 8 
48 9.24 ± 0.20 8.83 ± 0.66 8.87 ± 0.56 71 ± 1 78 ± 5 78 ± 7 
72 9.63 ± 0.87 10.21 ± 0.31 9.17 ± 0.49 73 ± 6 89 ± 4 81 ± 5 
120 9.41 ± 1.01 8.88 ± 0.38 8.58 ± 0.40 73 ± 6 76 ± 3 75 ± 2 
 
4.3. Results and Discussion 
4.3.1. Single Compound Sorption and Desorption 
Compound sorption reached steady state within 2-3 days at 20 ppm of each compound, 
with 50-60% being sorbed within the first 16 hours of incubation (Table 4.4).  While the total 
mass sorbed of each compound increased from ~10 g in a 20 ppm solution to 28-35 g per 1 kg of 
dry soil in an 80 ppm solution (Figure 4.2), the percent of the sorbed FQs decreased from ~90% 
for all three FQs at 20 ppm to 76.7 ± 5.1% for NOR, to 72.1 ± .06% for OFL, to 62.3 ± 3.2% for 
CIP at 80 ppm.   
The data in Table 4.5 show that KD also decreased as a function of sorbate concentration. 
In regards to desorption, the KD values for all concentrations yielded the following trend: NOR > 
CIP > OFL.  For OFL, CIP, and NOR the percentage desorbed (20 ppm : 80 ppm) were 4.07 ± 
0.76 : 11.83 ± 0.97; 3.76 ± 0.75 : 6.09 ± 1.18 and 2.04 ± 0.25 : 5.31 ± 1.44, respectively (Figures 
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4.3a-c). The overall trend is that FQs bind less tightly at higher concentration, with OFL being 
most loosely bound to the studied soil.  These results lead to three questions: 1) why does the 
studied soil have its sorption capacity, where does a soil sorption capacity come from, 2) what is 
the mechanism of sorption and 3) are there different sorption sites?  In order to answer the first 
question one must study the sorbent.  The studied soil contained 1830 mg kg-1 Ca (1756 mg kg-1 
exchangeable), 29,284 mg kg-1 Al (11 mg kg-1 exchangeable) and 11,072 mg kg-1 Fe (170 mg kg-
1 exchangeable), an overall cation exchange capacity (CEC) of 19.8 cmolc kg-1  with a clay 
content of 31.3%, and organic matter content of 18.5 ± 1.0% (Tables 4.1 and 4.2).  Ca, Al, and  
 
 
Figure 4.2. Soil sorption capacity for an initial concentration range from 20 to 100 mg L-1 
Fe are known to complex with fluoroquinolones and have been found to play an important role in 
a soil’s FQs sorption capacity (Gu and Karthikeyan, 2005; Zhang and Huang, 2007; Zhang and 
Dong, 2008).  In addition, cation exchange is also an important mechanism for the sorption of  
FQs (Lee et al., 2007b).  The soil has a high percentage (18%) of organic matter which has also 
































Table 4.5. Sorption and desorption data for mass of soil and percent of each compound sorbed along with the KD values at 





g kg-1 Dry Soil % Sorbed KD         (cm3 g-1) 
CIP NOR OFL CIP NOR OFL CIP NOR OFL 
20 10.5 ± 0.4 10.1 ± 0.13 10.1 ± 0.3 89.2 ± 1.3 91.0 ± 1.9 88.3 ± 1.3 4844 ± 628 5791 ± 1280 4325 ± 634 
30 14.7 ± 0.8 15.8 ± 0.64 14.5 ± 0.8 85.2 ± 4.7 91.5 ± 0.8 85.0 ± 5.5 3587 ± 1730 6234 ± 727 3541 ± 1291 
40 18.5 ± 3.2 20.5 ± 0.4 16.5 ± 1.5 80.5 ± 9.5 90.0 ± 2.8 72.8 ± 5.9 2798 ± 1405 5382 ± 1422 1576 ± 530 
50 22.3 ± 0.6 25.2 ± 0.2 22.4 ± 1.0 75.6 ± 2.6 89.4 ± 2.5 80.7 ± 3.9 1835 ± 267 4984 ± 1177 2387 ± 587 
60 23.6 ± 2.6 28.1 ± 1.6 24.0 ± 3.0 69.0 ± 6.7 83.6 ± 4.4 70.5 ± 8.0 1338 ± 520 3073 ± 1035 1471 ± 630 
80 28.2 ± 1.3 34.8 ± 2.4 33.7 ± 1.1 62.3 ± 3.3 76.7 ± 5.2 72.1 ± 0.6 934 ± 127 1942 ± 450 1496 ± 82 
Desorption 
20 10.1 ± 0.3 9. 9 ± 0.1 9.7 ± 0.3 3.8 ± 0.8 2.0 ± 0.3 4.1 ± 0.76 5431 ± 1029 10005 ± 1308 5042 ± 1044 
30 14.0 ± 0.7 15.3 ± 0.5 13.6 ± 0.7 4.8 ± 0.7 3.1 ± 0.6 5.9 ± 1.2 4021 ± 659 6664 ± 1530 3376 ± 762 
40 17.7 ± 2.7 19.6 ± 0.4 15.1 ± 1.4 6.3 ± 1.3 3.3 ± 0.2 7.6 ± 2.0 3168 ± 765 6281 ± 375 2519 ± 644 
50 21.1 ± 0.6 24.3 ± 0.3 20.8 ± 1.1 5.4 ± 1.4 3.7 ± 0.7 7.2 ± 0.4 4071 ± 1390 5407 ± 972 2569 ± 166 
60 22.0 ± 2.6 27.1 ± 1.4 21.8 ± 2.9 6.9 ± 1.3 3.6 ± 0.9 10.4 ± 2.1 2788 ± 621 5733 ± 1257 1796 ± 395 
80 26.5 ± 1.0 32.9 ± 1.8 29.7 ± 0.9 6.1 ± 1.2 5.3 ± 1.4 11.8 ± 1.0 3224 ± 717 4017 ± 1449 1573 ± 135 
55 
 
that a number of mechanisms can be envisioned to be at play in the sorption of FQs to this soil, 
and hence, within a wetland WWTP.  From an applied point of view, the results above do show 
that: (i) the wetland soil under study has a high sorption capacity for the FQs, (ii) FQs are rapidly 
sorbed, and (iii) other removal mechanisms (e.g. photodegradation) probably play a minor role 
reducing the remaining concentration in the aqueous phase.   
Insight into the sorption mechanisms comes from batch sorption data fitted with the 
Freundlich isotherm.  Log transformed values of Freundlich sorption coefficients (KF) of FQs 
give the trend NOR (4.09) > CIP (4.01) > OFL (3.9). Desorption KF values are higher but show a 
similar behavior: NOR (4.24) > CIP (4.12) > OFL (4.05). In addition, sorption-desorption 
isotherms are hysteretic and highly non-linear (Table 4.6; Fig 4.3).  In another study, OFL had 
Log KF of 3.75 in a soil with pH = 4.3, 7.1% OC, 57.52% sand, 26.64% silt and 15.84% clay, 
which is slightly lower, but the same order of magnitude as our value (Drillia et al., 2005). In 
contrast, our KF values are lower than those published (Zhang and Dong, 2008) for two of the  
Table 4.6. Freundlich Isotherm values for sorption and desorption of each compound. 
Information on Freundlich calculations are located in supplemental information. 
Fluoroquinolone 
Sorption Desorption 
N KF R2 N KF R2 
Ofloxacin 0.40 ± 0.05 3.90 ± 0.05 0.74 0.46 ± 0.03 4.05 ± 0.02 0.92 
       
Ciprofloxacin 0.28 ± 0.04 4.01 ± 0.04 0.74 0.44 ± 0.03 4.12 ± 0.01 0.92 
       
Norfloxacin 0.38 ± 0.04 4.09 ± 0.03 0.81 0.49 ± 0.03 4.24 ± 0.01 0.91 
 
three mineral soils for NOR, 4.32, 4.45.  This wetland soil has a pH of 6.87, ~10% OC, 66.40% 
sand, 31.31% clay and 19 cmol kg-1 CEC. Thus, it is likely that sorption of these FQs is not only 
due to its associations with the minerals present in soil, but also to the soil organic matter (SOM) 
content. In addition, pH and ionic strength also influence sorption of charged organic  
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                               a) 
 
                                   b) 
 
          c) 
 
Figure 4.3. Sorption and desorption of each compound. The x-axis represents the initial 
compound mass in solution.  The y-axis represents either the compound mass on the soil 
(sorption) or the compound mass desorbed (desorption) at pseudo-equilibrium after three 





























































compounds.  Also, Zhang and Dong (2008) found that the presence of low molecular weight 
organic acids decreased the sorption capacity of NOR in a mineral soil.  Therefore, the presence 
of organic materials in the Bayou Castine soil may have contributed to a decrease in the 
fluoroquinolone sorption capacity.  
The studied fluoroquinolones have two different pKa values: carboxylic (pKa1 = 5.90 - 
6.23) and amino (pKa2 = 8.28 - 8.89) (Tolls, 2001; Pico and Andreu, 2007). Since the pH of 
Bayou Castine soil is 6.87, during the sorption process a greater fraction of FQs (~80%) exist in 
zwitterionic or neutral form, whereas the remaining portion is cationic. The presence of charged 
groups in an organic molecule enables ion-ion as well as ion-dipole interactions, which in turn 
greatly influence sorption to mineral/clay surfaces as well as to SOM. Neutral molecules can also 
be sorbed by various retention mechanisms, such as hydrophobic forces, hydrogen-bonding, ion-
dipole, and aromatic electron donor-acceptor processes depending on their chemical structures.  
For this reason, high potential for sorption to both the mineral phase and SOM within this soil is 
expected. 
The highly nonlinear nature of Freundlich isotherms of FQs in this study suggests that 
site specific interactions of varying energies largely contribute to FQ sorption, aside from 
nonspecific hydrophobic forces. Nonlinearity in sorption of organic compounds with charged 
groups, and even of unionized polar organic compounds, is expected (Chiou et al., 2000; 
Schwarzenbach et al., 2003). Sorption isotherm nonlinearity of NOR and OFL (N=0.76 and 0.61, 
respectively) to highly mineral soils with OC<0.5% have been observed (Drillia et al., 2005; 
Zhang and Dong, 2008).  The hysteresis is further enforced by desorption KF > sorption KF.  The 
experimental design makes artificial hysteresis very unlikely. Thus, the observed hysteresis can 
be considered as real and attributable to mineral hydrophobic nanosites, sorbate-induced 
rearrangement of the SOM matrix during sorption, and the creation of rigid and dilated pores, 
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which may not fully relax back during the desorption process (Xia and Pignatello, 2001; Sander 
et al., 2006).  The organic matter within the Bayou Castine soil may actually compete with the 
FQs for available binding sites, as indicated by the decreased the sorption capacity of NOR in a 
mineral soil in China in the presence of low molecular weight organic acids (Zhang and Dong, 
2008). 
The data above indicate that there is a distribution of sites capable of sorbing FQs within 
the investigated wetland soil.  This conclusion comes from 1) the difference observed in binding 
constants at different concentrations, 2) the change in the order of binding constants among FQs 
as a function of concentration and 3) the observed hysteresis.  These points also lead to the 
possibility of competition between FQs for sorption sites within the wetland soil under study.  
4.3.2. Multi-compound (Competitive) Sorption and Desorption 
In order to address the possibility of competition between the studied FQs for the sorption 
sites within the soil, three different scenarios were explored, as illustrated in Figure 4.1.  Each 
individual FQ was sorbed at a 20 ppm concentration.  Additionally, all three compounds, each at 
20 ppm, were simultaneously sorbed for a cumulative 60 ppm FQ concentration.  Finally, each 
FQ was studied individually at a concentration of 60 ppm.  The results of this analysis are 
presented graphically in Figure 4.4.  From the data it can be seen that the individual compound 
sorption KD values at 20 ppm showed no significant difference (CIP & NOR p = 0.523, CIP & 
OFL p = 0.601, NOR & OFL p = 0.243), while at 60 ppm, NOR had a statically greater KD value 
compared to CIP (p = 0.01) and OFL (p = 0.016), with a general trend of NOR>OFL=CIP.  The 
KF from the Freundlich fits also show preferential sorption for NOR, followed by CIP. These KD 
results are not unexpected and are in fact consistent with what would be predicted based on the 







 Figure 4.4. Sorption and desorption KD values showing competition compared to 
individual values at 20 and 60 ppm. The 20 and 60 ppm values represent 1 single 
compound in solution at that concentration. Competition data represents all 3 compounds 
(CIP, NOR, OFL) in solution at 20 ppm each, for a cumulative concentration of 60 ppm. 
Letters represent subsets of comparisons between treatment levels (ie. 60 ppm CIP vs. 60 
ppm NOR vs. 60 ppm OFL, etc.). Numbers represent subsets of comparisons between 











































































If one now focuses on the multi-compound sorption data, it can be seen that the 20 ppm 
individual KD values are significantly higher than the 60 ppm mixture KD values for CIP (p = 
0.048) and OFL (p = 0.001). NOR KD values for 20 ppm individual analysis are not significantly  
different (p = 0.093) than the mixture KD (Figure 4.4a).  The 60 ppm individual KD for NOR is 
not statistically different from the KD for NOR in the 60 ppm mixture.  Both of these findings 
reinforce the hypothesis that NOR outcompetes the other two compounds for binding sites.  In 
fact, carrying out the same type of analysis reveals that the preferential sorption of NOR occurs 
when OFL is also present.  The same analysis shows that CIP lies between NOR and OFL.  
These findings suggest that: 1) NOR competes for OFL sites only and CIP has unique sites 
and/or 2) NOR and CIP compete with OFL for sorption sites. 
In terms of desorption, the KD values are as expected from the adsorption isotherm 
analysis at both 20 and 60 ppm.  No significant difference was observed between the mixture and 
20 ppm results for CIP and OFL (p = 0.095 and 0.267, respectively) (Figure 4.4b).  For NOR, the 
20 ppm individual KD value was significantly greater than that in the mixture KD (p = 0.01). 
Only OFL (p <0.01) had a mixture KD that was significantly greater than that in the 60 ppm 
individual solution.  In fact, the KD for OFL in the mixture was the same as for NOR mixture, 
which was unexpected, given the sorption data discussed above.  The data indicate that, while 
OFL is “outcompeted” in terms of total sorption site occupation, the site “quality”, as determined 
by sorption strength or irreversibility, partially reverses that effect. Results  demonstrate that the 
competition and 20 ppm values of OFL are significantly higher than 60 ppm OFL KD,des values, 
but that the 20 ppm and competition are not significantly different (Figure 4.4b). The lack of a 
difference between these two values demonstrates that while OFL sorbs less than NOR and CIP, 
it sorbs to higher quality sites in the presence of the other two compounds. While each of the 









Figure 4.5. Electrostatic potential surface models for a) CIP, b) NOR and c) OFL. Models, 
courtesy of Dr. Charisma Lattao, were generated using Sybyl 8.0 (Tripos International, St. 




sorbing to higher quality binding sites than for the other two compounds.  The reason for this 
phenomenon is understood when examining the electrostatic surface potential models of each 
compound (Figures 4.5a-c).  A highly negative surface potential exists on the carboxylic group 
while on the other end of the molecule, a positive electrostatic surface potential is situated on the 
amino group, depicting the zwitterionic or neutral form of FQs as having localization of charges. 
OFL however, has a more positive surface potential than CIP and NOR on the opposite end of 
the carboxylic group. Moreover, the aromatic moieties in FQ display neutral to minimal negative 
charges on its surface, whereas the different substituents attached to the nitroaromatic moiety 
exhibit the greatest positive charge concentration along the surface of the molecule.  
This is consistent with a previous suggestion by Carrasquillo et al. (2008) that the 
distribution of charges on the FQ molecule permits an orientation that allows optimal 
interactions with sorption sites. Hence, the carboxylate groups in FQs are capable of electrostatic 
interaction with the multivalent cations on the mineral phase and/or hydrogen bonding with 
natural organic matter, which is enhanced by a greater charge separation on the molecule. The 
net dipole of FQs is in the order OFL (8.63) > CIP (8.38) > NOR (8.09), which suggests that the 
neutral OFL molecule is the most polarized hydrophobic compound among the three FQs. Aside 
from other interactions, hydrophobic forces are also higher for OFL because of its larger 
hydrophobic surface, which also contributes to the observed trend. In addition, Zhu and 
Pignatello (2005) found that polarizability contributes between ~15-40% of sorption free energy. 
Therefore, compounds that are more polarizable are more likely to bind. In this case, charge-
dipole interactions are probable between the carboxylate and phenolate groups of the natural 
organic matter and the positively charged surface of the FQs. The combined sorption and 
desorption data (Figures 4.4a ad 4.4b) collectively provide the following evidence: 1) overall 
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NOR and, to a lesser extent, CIP outcompete OFL for sorption sites, 2) OFL sorbs to its share of 
“quality” sorption sites, and 3) competition only occurs for lesser “quality” binding sites.  
4.4. Environmental Implications 
Treatment wetlands continuously receive wastewater containing a suite of pharmaceutical 
compounds. The soils of these wetlands are responsible for a significant amount of aqueous 
concentration reduction of pharmaceutical compounds through sorption. The treatment wetland 
soil used in this study sorbed 60-90% of each compound within 2-3 days. The rapid sorption to 
the soil indicates that treatment wetlands do not need extended retention times in order to be 
effective at reducing aqueous concentrations of these compounds. If loading of each compound 
were halted, which is unlikely in a wetland receiving treated wastewater, the wetland soil would 
release a small percentage of the amount sorbed in the short term. Freundlich isotherm values 
were ~4 L kg-1, which also points to sorption as is a major removal pathway.  These data indicate 
that this soil has a significant ability to sorb and immobilize these FQs, mitigating any 
downstream releases during wastewater treatment. However, studies need to establish whether 
the release of low amounts of these FQs would continue over the long term.  The pH of 
freshwater wetlands, which are used to treat wastewater, have a pH between 6-7, therefore the 
small pH range will not significantly alter sorption when comparing different treatment wetlands. 
Sorption of compounds in wastewater to a wetland soil is complicated by the presence of 
a suite of pharmaceutical compounds and other wastewater contaminants. There is competition 
between the compounds studied for preferred binding sites. Therefore, one compound may 
decrease the sorption capacity of another compound, which may cause greater migration of 
compounds downstream. The competition effect is of particular concern in a treatment wetland 
wastewater where 10s to 100s of compounds have been detected (White et al., 2006).  White et 
al. 2006 also determined that some treatment wetlands may receive a significant mass of these 
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compounds annually (27 kg). Therefore, if sorption is the major removal pathway of these 
compounds from the aqueous phase, soils would need to be able to sorb large amounts of 
compounds without reaching saturation. This soil is capable of sorbing a significant amount of 
the pharmaceuticals studied, well above a daily loading rate. 
 These points, as well as viability of treatment wetlands over the course of decades, 
require further studies due to soils becoming increasingly more loaded with a range of 
pharmaceutical compounds, including antibiotics. The presence of competition between these 
three compounds demonstrates the need for more studies that examine the sorption of 
pharmaceuticals and personal care products in the aqueous environment in the context of waters 




CHAPTER 5: ANTIBIOTIC EFFECTS ON MICROBIAL RESPIRATION 




Since Alexander Fleming’s discovery of Penicillin in 1928, antibiotics have become a 
cornerstone for the health of our society and are used to maintain high levels of livestock and 
aquaculture production, along with human health (Kummerer, 2009a). These compounds are 
valued for their ability to interrupt the proliferation of specific bacteria. While antibiotics can 
occur naturally in the environment, a wide range of synthetic pharmaceuticals are now regularly 
detected in soil and water impacted from various sources (Kolpin et al., 2002; Batt et al., 2006; 
Karthikeyan and Meyer, 2006; White et al., 2006; Conkle et al., 2008; Barber et al., 2009).   
In wetlands, microbes facilitate many biogeochemical transformations, such as organic 
matter decomposition and a wide variety of nutrient transformations (Wright and Reddy, 2007; 
Ye et al., 2009). This important ecosystem function relies on microbes that break down organic 
matter in wetlands, thereby contributing to nutrient availability. Wetland microbes produce 
carbon dioxide (CO2), and methane (CH4) during oxidative respiration.  Additionally, denitrifiers 
facilitate the gaseous removal of nitrogen from wetlands by utilizing nitrate (NO3-) as their 
terminal electron acceptor, converting it to nitrogen gas (N2) through denitrification and in some 
systems N2O is also produced.  
Nitrogen is a limiting nutrient in many aquatic ecosystems. Therefore, it is important to 
reduce N loading to prevent eutrophication (Broussard and Turner, 2009). In some Louisiana 
communities, and many other places around the world, wetlands are used to treat wastewater 
(Chapman, 2003; Gray and Sedlak, 2005; Conkle et al., 2008). Wastewater can contain a range 
of pharmaceuticals, including antibiotics (Conkle et al., 2008). It is therefore important to 
determine if the loading of antibiotics to treatment wetlands has an adverse impact on the 
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function of the natural microbial communities, especially denitrifiers responsible for removing 
nitrate from wastewater. 
 Only two studies, to the author’s knowledge, have examined microbial respiration in the 
presence of pharmaceuticals. Costanzo et al (2005) found that some antibiotics reduced the rates 
of denitrification (erythromycin, clarithromycin, amoxicillin), while amoxicillin/clavaulini 
showed no effect when soils were loaded with 1000 ppb. Ciprofloxacin was also tested over a 
concentration gradient from 0.1 to 1000 ppb and no effects were noticed (Costanzo et al., 2005). 
Fountoulakis et al (2004) examined the influence of pharmaceuticals on methanogenesis and 
determined that propranolol hydrochloride, diclofenac (sodium), carbamazepine and ofloxacin 
all inhibited rates, while sulfamethoxazole and clofibric acid showed no significant effects. 
However, in the study by Fountoulakis et al (2004), samples were tested over a concentration 
gradient of 10 to 400 ppm, which is 2 to 6 orders of magnitude higher than environmentally 
relevant concentrations (Fountoulakis, 2004). 
This study compliments their research by examining the effect of three antibiotic 
compounds, ciprofloxacin (CIP), tetracycline (TET) and sulfamethoxazole (SULF) on N2O, CH4 
and CO2 production in two wetland soils, with contrasting organic matter contents; peat and 
mineral (Table 5.1). Substrate induced respiration (SIR) rates were determined for CH4, N2O and 
CO2 production, while basal respiration rates were determined for CH4 and CO2. 
5.2. Materials and Methods 
 5.2.1. Test Solutions 
Tetracycline, ciprofloxacin and sulfamethoxazole (all > 98% purity) were obtained from 
Sigma-Aldrich (St. Louis, MO). Stock solutions of 20 ppm were prepared for each compound, 
which were then further diluted to a 5 ppm spike solution.  The 5 ppm spike solution of each 
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compound was then injected into the sample bottles or tubes containing soil and solution at 
specific volumes to achieve the pre-determined treatment concentration. 
5.2.2. Site Description and Soil 
Mandeville, LA utilizes a system of lagoons and wetlands to treat wastewater, and is  
effective at reducing the concentration of pharmaceuticals discharged in its effluent (Conkle et 
al., 2008).  However, several of the detected compounds are still released, but at much lower 
concentrations into the adjacent forested wetland (Bayou Chinchuba) and ultimately Lake 
Pontchartrain. A nearby wetland soil from Bayou Castine (BC, 15R 784949 E, 3361530 N) was 
chosen for this study due to its proximity to Bayou Chinchuba and similar soil classification as 
an arat silty clay loam, which is a fine silty, siliceous, non-acid, thermic typic hydraquent 
(Trahan et al., 1990).  A peat soil was also chosen for analysis to compare the effects of 
antibiotics on soils with a significantly higher organic matter contents. The peat soil was taken 
from the Davis Pond (DP) freshwater diversion wetland (15R 0765814, 3307688) (Gardner and 
White, IN PRESS). This wetland receives water diverted from the Mississippi River, which has 
been determined to contain a wide range of pharmaceutical compounds (Zhang et al., 2007). 
Soils from the top 10 cm were collected, woody debris removed, homogenized and stored at 4 
°C.  Soil characterization included total and extractable metals (DeLaune et al., 2008) and total 
carbon and nitrogen and organic matter (White and Reddy, 2000). All analysis was performed on 
field moist soil. 
5.2.3. Methane and Carbon Dioxide Respiration Methods 
For determination of CH4, and CO2 production, 0.75 g dry weight of each soil was added 
to 27 mL anaerobic tubes, capped with a gas impermeable butyl rubber stopper and sealed with 




Table 5.1. Compounds used to examine antibiotic effects on wetland soil microbial respiration and various properties of each 2 
drug. 3 








Bactericidal Gram Negative Gram Positive 35% in 24 hrs Urinary Tract Infections 0.4
a 4.01c 
        
SULF 
 
Bacteriostatic Gram Negative Gram Positive 30% in 72 hrs 
Urinary Tract Infections 
Chronic Bronchitis 
Pneumonia 
0.89b 0.04 – 1.27b 










Respiratory Tract Infections 
Skin and Tissue Infections 
 
-1.19a 1.66 – 3.63d 
a Tolls 2001 4 
b Yu et al. 2009 5 
c Conkle et al. IN REVIEW 6 
d Jia et al. 2008, Gu et al. 2007 7 
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with 99.9% O2 free N2 for five minutes. Each vial was incubated at 25oC in an incubated orbital 
shaker at 100 rpm for 72 hrs and the headspace was again flushed for five minutes, prior to 
solution, substrate and antibiotic additions. Each vial received DI water to bring the total liquid 
volume of the vial to 15 mL, which includes the additions of one of five concentrations (1, 50, 
100, 500, 1000 ppb) of CIP, TET or SULF. Substrate induced incubations for CH4, and CO2 
were identical to basal incubations, except sodium acetate (23 g C kg-1 dry soil) was added to 
CH4 vials while glucose (30 g C kg-1 dry soil) was also added to CO2. 
Headspace gas samples were collected and analyzed once during the first 48 hours and 
then a week later, followed by bi-weekly sampling for up to two months for basal respiration. 
Substrate induced respiration samples were sampled daily for one week. Gas samples were 
analyzed for CO2 using a Shimadzu (Koyoto, Japan) GC-2014 fitted with a thermo conductivity 
detector operated at 160oC, utilizing a packed Poropak N (6 ft; 80/100 mesh) column, supplied 
by Sigma-Aldrich (St. Louis, MO), with an oven temperature of 80oC.  
Gas samples for methane basal respiration were analyzed bi-weekly for up to 2.5 months. 
Substrate induced CH4 samples were incubated and analyzed for 3 months. Samples were 
analyzed using a Shimadzu GC-2014 fitted with a flame ionization detector operated at 160oC, 
utilizing a packed Carboxyn 1000 (6 ft; 40/60 mesh) column, supplied by Sigma-Aldrich (St. 
Louis, MO), with an oven temperature of 110oC.  
Five point standard curves were run weekly and continuing calibrations within 5% were 
performed prior to each analysis. Standard gas consisting of 1.0% CO2, 1.0% CH4, 1.0% O2 and 
a balance of N2 was used for the calibration of both CO2 and CH4.  
5.2.4. Denitrification Methods 
The acetylene block method was used to determine the effect of antibiotics on 
denitrification (Yoshinari et al., 1977; Sorensen, 1978). Therefore, N2O evolution is used as a 
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proxy for the denitrification rate, where acetylene blocks the final reduction transformation of 
N2O to N2.  Approximately 0.75 g dry weight of the two soils were added to 70 mL serum 
bottles, capped with a gas impermeable butyl rubber stopper and sealed with an aluminum crimp. 
Only substrate induced respiration (added carbon and nitrate) was measured for denitrification. 
Serum bottles were evacuated to < -88 Kpa and then flushed with 99.9% O2 free N2 gas for five 
minutes to assure anaerobic conditions. Each bottle was incubated at 25oC in an orbital shaker at 
100 rpm for 72 hrs and the headspace was again flushed with N2 gas for 5 minutes. Each bottle 
then received one of five concentrations (1, 50, 100, 500, 1000 ppb) of CIP, TET or SULF and 
DI water before being incubated for an additional 72 hours prior to additions of acetylene (15% 
of headspace) and substrate (glucose: 597 g C kg-1 dry soil , potassium nitrate: 73.8 g N kg-1 dry 
soil). Headspace gas samples were collected within the first five hours after substrate addition 
and then daily for 4-7 days. Gas samples were analyzed using a Shimadzu GC-8A fitted with an 
electron capture detector operated at 150oC, utilizing a packed Poropak Q (6 ft; 80/100 mesh) 
column, supplied by Sigma-Aldrich (St. Louis, MO), with an oven temperature of 50oC. All 
samples were incubated in triplicate, with blanks consisting only of soil, DI water and substrate 
(if SIR). 
Standard curves were run as needed and continuing calibrations (within 5%) were 
performed prior to each analysis. Standard gas consisting of 10 or 100 ppm and a balance of N2 
was used for the calibration of the N2O standard curve.  
5.2.5. Data Analysis and Statistics 
Substrate induced respiration rates were calculated for the initial rate, prior to an 
exponential increase in gas concentration, and for the maximum (potential) rate. Basal 
respiration rates were determined to be the maximum rate observed during the incubation.  If 
there was a visible lag with one or more of the treatments, an intermediate rate was also 
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calculated, and is referred to as the delay rate. The potential rates represent the maximum 
capacity of the microbes produce each gas.  Due to the addition of substrates to create non-
limiting conditions, potential rates are significantly higher than what would be expected in 
normal environmental conditions. All rates are the average of the maximum rates of each 
respiration phase for each individual sample vessel within that treatment.  Outliers were removed 
from each analysis, and respiration rate differences were determined using a one-way ANOVA. 
A Latin Square Design (LSD; p < 0.05) model was used when equal variance was met, and a 
Dunnett’s T3 test when equal variances were not met. Determination of outliers and ANOVA 
analysis was performed using SPSS 17 (SPSS Inc., Chicago, IL), while correlations were 
determined using Excel 2007 (Microsoft Corp., Redmond, Wash). All drug compounds were 
obtained from Sigma-Aldrich (St. Louis, MO). 
5.3. Results 
The total carbon content varied between the two soils, with the Davis Pond peat soil 
containing 232 g C Kg-1 and the Bayou Castine containing 60 g C Kg-1. This carbon difference 
let to significant differences between the respiration rates of blanks (no antibiotic) for each of the 
soil types.  The respiration rates were higher in the peats soils for CH4 and CO2 basal respiration 
(5.8, 2.5 times larger, respectively) and SIR initial (65.4, 5.1 times larger, respectively) than the 
mineral soil. However, there is no significant difference between the mineral and peat soils when 
measuring the potential SIR rate for CO2 or CH4 and N2O. Therefore, under non carbon limiting 
conditions, both soils are potentially capable of reaching similar microbial activities.  
5.3.1. Basal Respiration 
 Carbon dioxide production in wetlands is an indicator of overall microbial activity, while 
methane production is linked to a specific group of organisms called methanogens.  Both gases 
are a byproduct of microbial breakdown of organic matter. These two gases are produced by 
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different bacteria that are predominant at either highly reduced (CH4) or moderately reduced to 
aerobic (CO2) conditions in wetland soils. Microbial function in wetlands is essential to organic 
matter decomposition and nutrient availability. 
 
Figure 5.1. Basal respiration rates of carbon dioxide in the peat and mineral soils. Letters 
represent significant differences in treatment respiration rates. Respiration was negatively 
correlated with treatment concentrations for 5.1a. 
 CIP-CO2: There was no significant correlation for CO2 respiration rate with concentration 
or differences between treatment concentrations for the peat and mineral soils.  
SULF-CO2:  The mineral soils exhibited lower respiration rates at the higher 
concentrations (500 < 1, 50; p = 0.036, 0.010 and 1000 < 50; p = 0.026) (Figure 5.1a). There was 
a significant negative correlation with respiration rate and treatment concentration for the 
mineral soil under basal respiration for CO2 (ρ = -0.569). In the peat soil there were lower 



















































































  TET-CO2: There were no significant relationships in the peat soil. The mineral soils 
amended with TET produced a significantly higher respiration rate for the 50 ppb treatment 




Figure 5.2. Basal respiration rates of methane in both the mineral and peat soils. Letters 
represent significant differences in treatment respiration rates. Respiration was positively 

































































































































 CIP-CH4: There was only one significant effect between treatments for CH4 basal 
respiration in either the peat or mineral soils. Higher CIP treatment concentrations in the mineral 
soil were significantly correlated with higher CH4 basal respiration rates (ρ = 0.489) (Figure 
5.2a).  
SULF-CH4: There was significant basal respiration suppression at lower treatment 
concentrations in the peat soil, where the blank, 500 and 1000 ppb were significantly higher than 
1 (p = 0.022, 0.003, <0.00) and 50 (p = 0.001, <0.00, <0.00) ppb, and 500 and 1000 were higher 
than 100 (p = 0.09, 0.015 respectively) ppb (Figure 5.2b).  Also 100 ppb was significantly higher 
than 50 (p = 0.025) ppb, indicating that there is less of an effect at 100 ppb, even though it is still 
measurable. There was also a significant positive correlation for basal respiration rates and 
treatment concentration in the peat soil (ρ = 0.590). 
The mineral soil CH4 basal respiration rates exhibited the opposite trend from the peat 
soil in the presence of SULF, with suppression of respiration at higher concentrations. 
Respiration in the 500 ppb treatment was significantly lower than respiration in the blank (p = 
0.024) ppb (Figure 5.2c).  
  TET-CH4: There were a couple significant relationships associated with basal respiration 
in the peat soil for CH4, where 100 is greater than 500 (p = 0.023) ppb and the blank (p = 0.037), 
while the 1000 ppb treatment is also greater than 500 (p = 0.045) ppb (Figure 5.2d). In the 
mineral soil the 500 ppb treatment respiration rate was significantly higher than the other 
treatments, including the blank (Figure 5.2e). 
5.3.2. Substrate Induced Respiration 
CIP-CO2: There were no significant differences between SIR treatments or correlations 
with concentration for CO2 in the mineral soil.  Only the 50 ppb treatment was significantly 
greater (p = 0.016) than the 100 ppb treatment for the peat soil (Figure 5.3a).  
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SULF-CO2: Respiration rates were significantly different between several treatments in 
the peat soil. The initial CO2 respiration rates of the blank and 500 ppb were higher than 1 (p = 
0.011, 0.010 respectively), 50 (p = 0.044, 0.043 respectively) and 100 (p = 0.031, 0.030 
respectively) ppb treatments. This was evidence of respiration supressesion at lower 
concentrations for the initial rate, since the blank was higher than the 1, 50, and 100 ppb 
treatments (Figure 5.4a).  
 Higher concentration treatments for the peat soil CO2 potential respiration produced 
significantly higher respiration rates, with 500 ppb being higher than blank (p = 0.004), and 100 
(p = 0.045). An increase in respiration rate was significanly correlated with SULF treatment 
concentration (ρ = 0.4908) (Figure 5.3b). 
 
Figure 5.3. Potential substrate induced carbon dioxide respiration rates for the peat and 
mineral soils. Letters represent significant differences in treatment respiration rates. 










































































The application of SULF to the mineral soil presented the clearest example of antibiotic 
suppression of microbial respiration. There was a time lag (Figure 5.5) where CO2 production in 
500 and 1000 ppb treatment lagged behind all other treatments during the first 60 hours of the 
incubation.  However, the total amount of gas evolved in these two treatments eventually reached 
comparable rates and concentrations to the other treatments. This result suggests that either the 
microbial community consortia changed or the microbial consortia present adapted to the 
antibiotics.  
 
Figure 5.4. Initial substrate induced carbon dioxide respiration rates for the mineral and 
peat soils for Sulfamethoxazole, along with the lag rates in the mineral soil. Letters 
represent significant differences in treatment respiration rates. Respiration was negatively 
correlated with treatment concentrations for 5.4b and c. 
There was a significant decrease in respiration rate correlated (ρ = -0.696) with treatment 
concentration and CO2 respiration rates for the initial SIR rate in the mineral soil (Figure 5.4b). 















































































expected, the lag in respiration rates were negatively correlated with increasing concentration ( 
= -0.823) (Figure 5.4c).  The blank and 1 ppb concentration were significantly higher than 500 (p 
= 0.017, 0.027 respectively) and 1000 (p = 0.016, 0.021 respectively) ppb treatments for the 
delay rates.  
 
Figure 5.5. Initial and potential substrate induced methane respiration rates for the peat 

































































































































TET-CO2: The only significant relationship observed in the mineral soil was for 
respiration in the blank, which was significantly higher than respiration in the 1 ppb treatment (p 
= 0.036) (Figure 5.3c). 
 CIP-CH4: For CH4, there were no significant differences between treatments or 
correlations for the peat and mineral soils. 
 
Figure 5.6. Carbon dioxide concentration increase with time for sulfamethoxazole in the 
mineral soil. A lag in respiration is observed for both the 500 and 1000 ppb treatment levels 
between 20 and 60 hours. 
SULF-CH4: There were several significantly different respiration rates with the initial 
SIR for the peat soil (Figure 5.6a). There was suppression at lower concentrations where 
respiration in the 1 treatment ppb was significantly less than respiration in the blank (p = 0.005), 
500 (p = 0.008) and 1000 (p = 0.035) ppb treatments. The respiration for the 50 ppb treatment 
was also significantly less than the blank (p = 0.016) and 500 (p = 0.026) ppb treatments. The 
data for potential methane SIR rate in the peat soil showed that methane production in the 500 
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and 1000 (p = 0.005) ppb treatments.  Respiration in the 50 ppb treatment was also significantly 
higher than respiration in the blank (p = 0.041) (Figure 5.6b). There were no significant 
differences between treatments or correlations for the mineral soil associated with substrate 
induced methane respiration 
TET-CH4: The initial SIR methane respiration rate for the peat soil produced 
inconclusive results, with 50 ppb treatment respiration rates being significantly higher than 
respiration in 1 (p = 0.008), 100 (p = 0.012) ppb treatments and the blank (p = 0.026), while 
respiration in the 500 ppb treatment was also higher than respiration in the 1 (p = 0.002), 100 (p 
= 0.003), 1000 (p = 0.035) ppb and the blank (p = 0.005) (Figure 5.6c).  The peat potential SIR 
rates were significantly higher treatments for the 1000 and 500 ppb treatments compared to the 
blank (p = 0.003, 0.002), 1 (p = 0.027, 0.022) and 100 (p = 0.034, 0.028) ppb treatments (Figure 
5.6d) The 50 ppb treatment was also higher than the blank (p = 0.016).  There was also a 
significant positive correlation with increased concentration (ρ = 0.635).  
The only significant substrate induced relationship observed for methane in the mineral 
soil was for the initial rate, where the rates in the 1,000 and 500 ppb treatments were 
significantly higher than the respiration rates in the 1 (p = 0.026, 0.024) and 50 (p = 0.030, 
0.027) ppb treatments (Figure 5.6f). 
5.3.3. Denitrification 
 CIP-Denitrification: The initial denitrification rate for the peat soil revealed that at lower 
concentrations there was a significant increase in N2O rates compared to rates in the blank and in 
treatments at higher concentrations (Figure 5.7a).  Denitrification in the 1 ppb treatment was 
significantly higher than rates in the 50 (p = 0.012), 500 (p = 0.002) and 1000 (p = 0.008) ppb 
treatments and the blank (p = 0.050), while denitrification at 50 ppb was higher than the rates in 
the 500 (p = 0.019) and 1000 (p = 0.010) ppb treatments and the rates in the 100 ppb treatment 
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was higher than the rates for the blank (p = 0.027). There were no significant relationships 
between treatments for the potential rate in the peat soil.  
 
Figure 5.7. Potential and initial denitrification rates for CIP in both the mineral and peat 
soils. Letters represent significant differences in treatment respiration rates. 
There was a significant difference for the initial denitrification rate for mineral soil, 
where the rate in the 50 ppb treatment was significantly lower than the rate in the 100 (p = 
0.045), 500 (p = 0.037), 1000 (p = 0.045) ppb treatments and the blank (p = 0.016) (Figure 5.7b).  
The rates for the 1 ppb treatment was also significantly lower than the rates in the blank (p = 
0.025). There were no significant differences between treatments for the mineral soil with the 
denitrification potential rates. 
 SULF-Denitrification: There were no significant differences in denitrification rates 
between treatments or correlations observed in experiments with the peat soil.  Three 
denitrification rates (initial, delay, potential) were calculated for mineral soil due to an apparent 
lag in respiration by the two highest concentration treatments (Figure 5.8a,b). There were no 
significant differences or correlations for the initial respiration rates. The lag and potential 
respiration rates both showed a significant negative correlation with increased concentration (ρ = 
-0.626, -0.846). However, only one significant relationship was observed, where 1000 ppb 
treatment respiration rate was significantly lower than respiration rate for the 1 (p = 0.042) ppb 




















































 TET-Denitrification: No significant relationships for denitrification rates were observed 
in the peat soil. Only one significant difference was observed for denitrification rates between 
treatments in the mineral soil, where the respiration rate for the 1 ppb treatment was significantly 
higher than the respiration rates of the blank (p = 0.023) and 50 (p = 0.0) and 1000 (p = 0.035) 
ppb treatments for the initial rate (Figure 5.8c). Any increase in respiration due to 1 ppb of TET 
was overcome when measuring the potential respiration rates, where there were no significant 
relationships between treatments. 
 
Figure 5.8. Delay and potential denitrification rates for sulfamethoxazole and the initial 
denitrification rates for tetracycline. Letters represent significant differences in treatment 
respiration rates. Respiration was negatively correlated with treatment concentrations for 
5.8a and b. 
5.4. Discussion 
Antibiotics are used to either kill bacteria or prevent their proliferation. Consequently, it 
was expected that the exposures to antibiotics in high (500, 1000 ppb) concentrations would stop, 





































































respiration and only in the mineral soil exposed to SULF, did we observe a decrease in 
respiration and a delay, which was relatively short-lived.  The remaining samples produced 
mixed results, with some treatments increasing respiration rates, while others only decreasing 
respiration with the low concentration treatments. 
The respiration suppression due to SULF was observed for basal rate of CH4 and the 
initial and delayed SIR rate for CO2. The suppression of CO2 rates for the initial and delay were 
short lived (~40 hours). The CO2 rates for SIR potential recovered over the span of a couple days 
to exceed the mean potential rates for the other treatments, while also reaching similar total 
respiration concentrations of CO2. Therefore, there was equal activity after the microbial 
community recovered from the initial exposure to SULF when in the presence of a substrate. In 
the mineral soil, the short term effects of SULF were overcome in a non-carbon limiting 
environment. We offer two possible explanations for the rapid recovery are: (1) there was a shift 
in the composition of the microbial community at the higher drug concentration treatments, or 
(2) the higher concentrations drug created a new readily available carbon pool of dead microbes, 
which fed the remaining microbes sparking a surge in respiration activity.  Soil contains a wide 
range of consortia of microbial organisms.  Antibiotics could only affect certain microbes in this 
consortia, which may have lead to the mixed results we observed. 
Several treatments revealed that there was suppression of respiration at lower 
concentration (1, 50 and sometimes 100 ppb) in relation to the blank, 500 and 1000 ppb 
treatments. This was observed for three instances with SULF and once with CIP. All instances 
occurred during basal respiration or with the initial rate for substrate induced respiration. The 
relationship was observed for CH4 and CO2 respiration with SULF treatments and for 
denitrification with CIP treatments. These results demonstrate that the concentrations, which are 
“environmentally relevant”, have the potential to affect the microbial population. The reason for 
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impacts at lower concentration and not higher concentrations is not fully understood. However, 
as previously mentioned, there may have been a shift in the microbial community composition at 
high concentrations to make up for the impacts of the antibiotics. There may be some antibiotic 
influence on the microbial community at higher concentrations, but it was not observed with 
regards to the respiration rates.  Experiments examining the microbial community composition 
are needed to understand the effects observed at higher treatment concentrations. 
Respiration increased at the lower concentration treatments in the peat soil with CIP for 
the initial denitrification rate.  The increase in respiration was reversed with the potential rate, 
where the mean rates of respiration in the 1 and 50 ppb treatments were suppressed compared to 
respiration in the blank and high concentrations after 140 hours (Figure 5.9).  
Figure 5.9. N2O increase with time for CIP in the peat soil. A decrease in respiration is 
observed for both the 1 and 50 ppb treatment levels between 80 hours and the end of the 
incubation at 140 hours. 
Increased respiration rates for CIP basal methane respiration were significantly correlated 
with higher gas evolution in the mineral soil. The incubation period for these samples was 2.5 
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mineral soils under highly reducing conditions, the antibiotics may lose some of their antibiotic 
properties and act as a substrate for the initial background microbe community in this soil. A 
previous study found that CIP increased microbial biomass when tested under anaerobic 
conditions (Cordova-Kreylos and Scow, 2007). This result was explained as a decrease or 
complete loss of antibiotic activity in an anaerobic environment (Lewin et al., 1991; Zabinski et 
al., 1995; Cordova-Kreylos and Scow, 2007) or even bacterial resistance. Bacteria have also 
been found to subsist on antibiotics (Dantas et al., 2008), but this has not been studied in wetland 
or submerged soils.   
The potential CO2 respiration rate exhibited a positive increase with concentration for the 
peat soil. The positive correlation occurred after suppression at the low antibiotic concentration 
in the peat for the initial rate measurements. In the mineral soil, there were negative rate 
correlations with antibiotic concentrations for both the initial and delay respiration rates.  The 
decreasing rate trend was overcome for the potential rates, and the high concentrations exhibited 
slightly higher rates than the lower concentration treatments.  This may be due to some selective 
pressure exerted on the microbial community by SULF. The positive correlation in the mineral 
soil appeared to be a result of a rebound effect after the high concentration treatments respiration 
was suppressed and delayed compared to the blank and low concentration amendments.  
All of the negatively correlated respiration rates with drug concentration occurred with 
the SULF treatments. They were seen in the mineral soil CO2 basal, initial and delay SIR, and 
the mineral N2O delay and potential SIR. With the exception of the N2O potential rate, all other 
negative correlations occur prior to respiration rates peaking due to the substrate addition. The 
mineral N2O incubation was ended after only 96 hours. Therefore, it is not known if the rate or 




Cordova-Kreylos and Scow (2007) determined that redox potential may play a role in the 
function of antibiotic compounds in the environment. The antibiotic properties of antibiotic 
compounds may be reduced or negated under highly reducing conditons (Cordova-Kreylos and 
Scow, 2007).  This may be what is occuring for basal methane respiration at high CIP (mineral) 
and TET (mineral and peat) concentrations. Under highly reducing (CH4) and basal conditions 
the respiration rates were positivley correlated with treatment concentration or the high 
concentration treatments were significantly higher than the blanks for CIP and TET, indicating 
that the antibiotic may act as carbon source (Cordova-Kreylos and Scow, 2007). Under less 
reducing (N2O) conditions, there appears to be a mixed effect on microbes, where the lower 
concentrations affected respiration the most.  The background (initial rate) microbe population in 
the peat soils produced more N2O when low concentrations were introduced, but as the 
incubation continued and the respiration rates increased the lower concentrations respired less 
than the higher concentration treatments. In addition, soil respiration under nitrate reducing 
conditions (denitrification) is mediated by a wide range of microbial groups (Salles et al., 2009) 
and antibiotics may only affect a small portion of these organisms, which explains the mixed 
results.   
Sorption of antibiotic compounds to soil (organic or mineral fraction) can be a pathway 
for PhAC removal from the water column (Hildebrand et al., 2006; Pan et al., 2009; Conkle et 
al., IN REVIEW). Cordova-Kreylos and Scow (2007) found that the magnitude of the effect of 
CIP on microbial communities was inversely related to compound sorption to the soil. This 
resulted in a reduced bioavailability and antibiotic potency of the compound (Cordova-Kreylos 
and Scow, 2007). CIP sorption to the mineral soil from Bayou Castine produced a Log KF value 
of 4.01 (Conkle et al., IN REVIEW). Log KF values from the literature for TET and SULF range 
between 1.66 – 3.63 and 0.04 – 1.27, respectively (Gu et al., 2007; Jia et al., 2008; Yu et al., 
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2009). Based on published values KF values, the general sorption potential follows this order: 
CIP > TET > SULF (Gu et al., 2007; Jia et al., 2008; Yu et al., 2009; Conkle et al., IN 
REVIEW). Reduction of antibiotic activity due to sorption explains why SULF exerts more of a 
negative influence on the soil microbes.  
TET and SULF are broad spectrum antibiotics which target a wide range of bacteria, 
while CIP is designed to target specific bacteria (Halling-Sørensen, 2001). Since CIP only targets 
a specific suite of bacteria, it could cause a shift in the microbial community dominance or alter 
their activity (Halling-Sørensen, 2001). TET is known to easily degrade in the environment due 
to light, pH and chelating metals (Halling-Sørensen et al., 2002).  This coupled with sorption 
may explain why there are less pronounced effects on respiration rates than what is found with 
CIP and SULF. 
5.5. Conclusions 
 Overall, SULF exhibited the greatest and TET the least influence on all microbial 
respiration parameters. Samples amended with TET demonstrated mixed interaction with regard 
to methane production in both soils.  No effects of TET addition were seen with regards to CO2 
or N2O production. The only significant relationships observed for CIP were seen in the mineral 
soil, where respiration was suppressed at low antibiotic concentrations during the initial phase 
and basal respiration for CH4 and N2O. A non-significant trend was also observed with the 
potential respiration rate in the peat soil for N2O production, where the low concentrations were 
suppressed compared to the high antibiotic concentrations and the blank.  
 In general SULF impacted both soils and the production of all three gasses (CH4, CO2 
and N2O). Suppression at high concentrations was observed in the mineral soils for the basal and 
initial rates. The suppression was overcome for both the CH4 and CO2 respiration rates when 
determining the potential rates, but N2O showed signs of suppression. The opposite trend was 
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observed in the peat soil, where there was suppression at lower concentrations for both CO2 and 
CH4. Any initial suppression of gas production rates were overcome when measuring the 
potential rate. 
 The general effect of each compound on microbial respiration appears to be tied to the 
sorption potential of each compound and the compounds overall stability.  The general sorption 
potential is CIP > TET > SULF.  TET is also known to be very unstable in the environment.  
Therefore, SULF is relatively more stable than TET and has a lower sorption potential, which 
may have resulted in the greater impact observed on microbial respiration. 
 At environmentally relevant concentrations, antibiotics, specifically sulfamethoxazole, 
may negatively impact microbial respiration in these wetland soils. Release of CH4, CO2 and 
N2O is a byproduct of microbial respiration/activity in wetland soils, and a decrease in 
respiration indicates that the microbial pool is less active. This finding has significant 
implications for wetland systems used to improve water quality, a common practice around the 
world. The efficiency of wetlands to treat and polish wastewater may be diminished due to the 
presence of antibiotics. 
 Microbes are essential to the overall function of wetlands, through the transformation of 
nutrient to bioavailable forms. The bioavailable forms of nutrients are essential to wetland plants 
and higher trophic levels. A reduction in bioavailable nutrients due to antibiotic impacts on the 
microbial pool may decrease the overall productivity of the wetland. In order to further 
understand the antibiotics effects on wetland soil microbial processes, studies addressing 




CHAPTER 6: CONCLUSIONS 
 
The environmental health of coastal Louisiana is directly tied to the maintenance of 
wetlands and “good” water quality. Wastewater containing excess nutrients and 
pharmaceutically active compounds is routinely discharged into surface waters, and has been 
shown to impair ecosystem health. Certain pharmaceutical compounds have been shown to 
negatively affect some fish species in rivers and streams (Chambers and Leiker, 2006). In a 
several Louisiana towns, wetlands are used to “polish” wastewater by removing excess nutrients 
prior to release into surface waters downstream. These treatment plants are not designed (nor are 
they required) to remove pharmaceuticals during the treatment process. The interactions and fate 
of many pharmaceutical compounds in the environment remains unknown. Research into these 
processes must be conducted prior to implementing any policies requiring pharmaceutical 
removal during wastewater treatment. We investigated whether wetlands are effective at 
removing certain pharmaceutical compounds. 
This research is among the first studies to examine the fate, transport and microbial 
effects of PhAC compounds in wetlands. Studies were conducted that focused  on identifying 
compounds entering wetlands and surface waters in Southeast Louisiana and their removal by 
wetland processes, understanding the fate of these compounds through sorption and desorption 
and examining the effects of antibiotics on wetland soil microbial respiration (CO2, CH4 and N2 
production).  
Research on compound loading from the Mandeville wastewater treatment plant, found 
that 13 of 15 target compounds were detected within the plant. Treated wastewater leaving the 
treatment plant contained only 9 of the 13 detected compounds above detection limits (low parts 
per-trillion).  The concentrations of many analytes were reduced by greater than 90% within the 
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wastewater treatment plant (WWTP). Several pharmaceuticals were not completely removed 
before discharge into Lake Pontchartrain, although their collective concentration was reduced by 
96% and lake loading was reduced to less than 1 kg yr-1.  The Mandeville WWTP and treatment 
wetland effectively reduced concentrations of various pharmaceuticals by several kilograms 
annually, decreasing potential contamination of Lake Pontchartrain and its fragile fisheries.   
In order to investigate sorption and desorption of antibiotics to a wetland soil, analytical 
methods utilizing direct analysis of aqueous samples (i.e. without extraction) and short retention 
times that allow for analysis of 100s to 1000s of samples in a reasonable time frame were 
required. Previously published methods were time consuming and not feasible for the proposed 
experiment. Two HPLC methods were developed for individual and simultaneous determination 
of ciprofloxacin, norfloxacin and ofloxacin.  Chromatography of individual compounds produced 
retention times between 1.5 and 2 minutes, and for simultaneous detection, retention times 
between 6.5 to 8 min. These methods are compatible with complex geomatrices, such as wetland 
soil.  The methods provide 1) detection limits in the low parts per-billion range, 2) decreases in 
retention times up to 6x times for single compounds, and up to 2x for simultaneous detection 
over published methods, and 3) requires no solid phase extraction. 
Sorption and desorption of three antibiotic compounds (ciprofloxacin, norfloxacin and 
ofloxacin) was determined on a mineral wetland soil from Bayou Castine, the control wetland for 
the Mandeville WWTP. Roughly 50% each compound sorbed within the first 20 hours of 
incubation and pseudo-equilibrium (60-90% sorption) was reached between 2 and 3 days. Only 
5-12% of the compound that sorbed was released from the soil over a 3 day period, indicating 
high loading onto the soil and low release.  Therefore, sorption to soil can be a major removal 
pathway for these compounds from the water column. We also examined competition between 
individual compounds for sorption sites. When multiple compounds were introduced to the soil, 
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the sorption potential of each compound decreased. Sorption and desorption results (single 
component and mixture) provided the following conclusions: 1) overall NOR and, to a lesser 
extent, CIP outcompete OFL for sorption sites, 2) OFL sorbes to its share of prefered sorption 
sites, and 3) competition only occurs for lesser “quality” binding sites. Multiple compounds in 
surface waters could lead to a decrease in sorption of certain compounds and a greater migration 
downstream. Therefore, future work that examines sorption of PhACs in wastewater need to 
investigate sorption in the presence of multiple compounds, since we have shown that there in 
competition between pharmaceuticals for sorption sites within this soil. 
The impact of antibiotics on soil microbial respiration was investigated in two wetland 
soils of contrasting carbon content. Tetracycline exhibited the least influence on microbial 
respiration, with only mixed effects on CH4 respiration in both the peat and mineral soil. There 
were, however, no noticeable trends or correlations between the respiration rates observed for 
TET and the concentration added to the soil. Ciprofloxacin only affected the respiration rates in 
the mineral soil, where at low antibiotic concentrations there was respiration suppression during 
the initial and basal rates for CH4 and N2O. 
Sulfamethoxazole impacted both soils and the respiration rates of all three analytes (CH4, 
CO2 and N2O). Suppression at high concentrations was observed in the mineral soil for the basal 
and initial rates. The suppression was overcome for both the CH4 and CO2 respiration rates when 
determining the potential rates, but N2O respiration potential still showed signs of suppression 
throughout the incubation period. The opposite trend was observed in the peat soil, where there 
was suppression at lower concentrations for both CO2 and CH4. This initial suppression of gas 
production rates was overcome when measuring the potential rate. 
 Antibiotics, specifically sulfamethoxazole, may negatively impact microbial respiration 
in these wetland soils. A reduction in respiration would indicate that the antibiotic is altering the 
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vital normal function of microbially mediated nutrient transformation in the wetland soil. This 
finding has significant implications when using wetlands to treat and polish wastewater, which is 
known to contain multiple pharmaceutical compounds including antibiotics. The efficiency of 
wetlands to treat and polish wastewater may be diminished due to the presence of antibiotics. In 
order to further understand the antibiotics effects on wetland soil microbial processes, studies 
must be conducted in the field and address the microbial community structure. 
 Our original hypotheses was that natural wetland treatment systems will remove 
pharmaceuticals from domestic wastewater in amounts that are equal to or greater than 
conventional wastewater treatment systems, and the major mechanism for removal (for most 
compounds) is sorption to particulates and sediments. The presence of multiple antibiotic 
compounds in a wetland will also result in competition for preferred binding sites between the 
compounds studied. Antibiotics will reduce the microbial activity in treatment wetlands. 
However, sorption may decrease the impact of antibiotics on wetland soil microbial 
communities. In addition, wetland soils that have previously sorbed pharmaceuticals may act as a 
source of pharmaceuticals if loading concentrations are decreased or stopped. 
 We found that these natural systems are effective at treating and removing PhACs from 
wastewater and that sorption can be a major removal pathway for particular compounds.  
However, when multiple compounds are present, which is normally the case in wastewater, there 
can be a decrease in the compound sorption potential due to competition between compounds for 
binding sites. Sorption to the soil appears to be strong enough to prevent significant desorption in 
the short-term (several days).  Although, there is some minor desorption (4 to 12% at 20 to 80 
ppm loading respectively) when the concentration gradient was reversed.  We found that 
antibiotics, at environmentally relevant concentration do possess the ability to affect the 
microbial communities in soils. 
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 The conclusions of this research have answered several questions but also shed light on 
areas that require more attention.  Future research that examines sorption and desorption in the 
context of a treatment wetland or wastewater in general should focus in greater detail on the 
effects of competition between the compounds for sorption sites. Studies that detect PhACs in 
the environment rarely find a single compound. Therefore, to more accurately understand 
removal mechanisms, sorption competition must be investigated. The microbial activity was 
determined based on gas evolution. However, an analysis of microbial communities, using 
molecular techniques also needs to be studied to shed more light on the results presented herein. 
Microbial activity was studied in a lab scale setting, which allows for determination of potential 
environmental effect.  This study could be scaled up to the field level to determine impacts on 
microbial activity at a larger scale.  Using enclosed soil cores with a flow-through system would 
be one way to incorporate both sorption and respiration into an experiment to gain a broader, 
collective understanding of antibiotic behavior in the wetland environment. 
The unique landscape of Louisiana allows small municipalities to use the natural 
environment to treat and “polish” wastewater using lagoons and wetlands. Most cities and towns 
discharge treated wastewater directly into surface waters such as the Great Lakes, Mississippi 
River or Atlantic Ocean. This research shows that using wetlands to “polish” waste water, rather 
than directly discharging treated effluent into surface waters, significantly reduces or prevents 
pharmaceutical migration downstream by reducing pharmaceutical compound concentrations in 
the water column. Antibiotics were found to exert a negative influence on microbial respiration, 
but the longer-term effects require further investigation. Overall, wetlands appear to be a useful 
tool in decreasing or preventing the release of potentially harmful pharmaceutical compounds 
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APPENDIX C: SORPTION AND DESORPTION DATA 
 



























20.20 10455.34 2.18 4844.02 10.80 89.20 
 
10060.31 0.72 5431.06 3.76 
31.23 14703.83 4.61 3587.42 14.77 85.23 
 
14012.77 1.36 4023.83 4.77 
40.40 18484.48 7.89 2797.78 19.53 80.47 
 
17737.01 2.21 3116.54 6.41 
50.50 22341.69 12.32 1834.63 24.39 75.61 
 
21140.64 2.69 4070.81 5.37 
60.60 23593.78 18.82 1337.56 31.05 68.95 
 
21978.00 3.56 2787.91 6.90 




































20.64 10092.50 1.81 5790.66 9.04 90.96 
 
9887.01 0.46 10004.69 2.04 
29.97 15788.16 2.55 6233.86 8.51 91.49 
 
15327.13 0.95 6663.62 3.12 
39.96 20427.70 3.99 5382.29 9.98 90.02 
 
19604.16 1.30 6281.23 3.28 
49.95 25240.80 5.29 4984.17 10.58 89.42 
 
24299.44 1.86 5407.29 3.73 
59.94 28133.33 9.81 3073.48 16.36 83.64 
 
27111.10 2.25 5732.66 3.61 




























20.20 10070.64 2.36 4324.84 11.66 88.34 
 
9660.37 0.81 5042.36 4.07 
30.30 14488.53 4.53 3541.12 14.96 85.04 
 
13638.55 1.61 3376.11 5.86 
40.40 16491.32 11.00 1575.61 27.23 72.77 
 
15105.77 2.36 2518.52 7.61 
50.50 22408.69 9.75 2386.90 19.30 80.70 
 
20801.25 3.16 2569.32 7.19 
60.60 24042.74 17.86 1471.08 29.47 70.53 
 
21847.30 4.72 1796.23 10.36 

















kd, ads           
(cm3 g-1) 
% in 









20.20 9971.40 2.75 3768.27 13.61 86.39 
 
3275.97 0.95 3681.71 5.21 
20.64 10372.69 2.49 4336.11 12.05 87.95 
 
3479.99 0.64 5939.13 3.30 















APPENDIX D: MICROBIAL RESPIRATION AVERAGE RAW DATA 
 
Table A-D.1. Average concentrations of BR methane evolved at each time interval for CIP 
(a), TET (b) and SULF (c) in the mineral soil 
a) 
  BC CIP CH4 BR 
Tmt 
(ppb) Time (hours) 
  529.5 864.5 1178 1532.5 1822.5 
  mg CH4-C Kg-1 dry soil Day 
1 0.003 0.023 0.036 0.038 0.036 
50 0.004 0.026 0.039 0.041 0.040 
100 0.003 0.024 0.037 0.039 0.037 
500 0.012 0.045 0.055 0.058 0.051 
1000 0.011 0.041 0.061 0.060 0.051 
BLK 0.016 0.040 0.054 0.055 0.050 
b) 
  BC TET CH4 BR 
Tmt 
(ppb) Time (hours) 
  529 864 1174.5 1534.5 1851 
  mg CH4-C Kg-1 dry soil Day 
1 0.001 0.011 0.024 0.027 0.025 
50 0.001 0.016 0.031 0.031 0.031 
100 0.009 0.033 0.048 0.045 0.040 
500 0.005 0.032 0.051 0.050 0.049 
1000 0.001 0.014 0.027 0.030 0.029 











  BC SULF CH4 BR 
Tmt 
(ppb) Time (hours) 
  527.5 863 1171.5 1531.5 1846 
  mg CH4-C Kg-1 dry soil Day 
1 0.002 0.018 0.029 0.030 0.025 
50 0.001 0.011 0.023 0.025 0.027 
100 0.001 0.013 0.022 0.034 0.035 
500 0.001 0.009 0.017 0.018 0.016 
1000 0.001 0.012 0.019 0.018 0.016 





















Table A-D.2. Average concentrations of SIR methane evolved at each time interval for CIP (a), TET (b) and SULF (c) in the 
mineral soil 
a) 
  BC CIP CH4 SIR 
Tmt 
(ppb) Time (hours) 
 
240 313.5 409.5 527.5 621 742.4 870.5 983.5 1087 1176 1272 1370 1463 1582 1680.5 1777.5 1917.5 2038.5 2185 2353.5 2502.5 2641 
  mg CH4-C Kg-1 dry soil Day 
1 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.001 0.002 0.004 0.008 0.031 0.090 0.244 0.871 1.761 4.322 5.088 5.285 5.575 
50 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.001 0.001 0.002 0.004 0.008 0.017 0.054 0.128 0.326 1.164 2.616 7.409 7.955 8.079 8.107 
100 0.000 0.000 0.000 0.000 0.000 0.001 0.001 0.002 0.003 0.008 0.042 0.248 0.727 1.235 1.373 1.987 3.530 3.843 4.274 4.821 5.201 5.506 
500 0.000 0.000 0.000 0.000 0.000 0.001 0.001 0.002 0.003 0.006 0.012 0.043 0.279 1.257 2.163 2.977 4.450 4.936 5.959 6.423 6.207 6.242 
1000 0.000 0.000 0.000 0.000 0.001 0.001 0.002 0.002 0.002 0.006 0.026 0.193 0.947 3.111 3.980 4.285 4.901 5.377 7.000 7.104 6.997 6.993 
BLK 0.000 0.000 0.000 0.000 0.000 0.001 0.002 0.002 0.004 0.007 0.017 0.035 0.087 0.405 0.900 1.793 3.253 4.471 7.060 7.293 7.363 7.315 
 
b) 
  BC TET CH4 SIR 
Tmt 
(ppb) Time (hours) 
 
240 313.5 408.5 527 621.5 743 870.5 983 1086 1174.5 1271.5 1369 1462.5 1581.5 1679 1777 1918.5 2039 2186 2353 2497 2637 
  mg CH4-C Kg-1 dry soil Day 
1 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.002 0.009 0.081 0.195 1.190 1.936 2.507 3.079 3.993 4.746 6.669 6.744 6.774 6.780 
50 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.002 0.008 0.078 0.676 1.586 1.913 2.084 2.552 2.852 2.583 1.012 1.050 1.103 1.281 
100 0.001 0.001 0.001 0.001 0.001 0.002 0.001 0.009 0.012 0.022 0.042 0.084 0.209 0.604 1.696 2.463 3.088 3.417 4.556 4.875 4.990 5.129 
500 0.000 0.000 0.000 0.000 0.000 0.001 0.001 0.002 0.003 0.008 0.024 0.102 0.467 1.610 3.138 3.054 3.381 4.710 4.808 4.842 4.836 4.821 
1000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.001 0.003 0.011 0.110 0.750 1.737 3.027 4.410 5.130 5.500 5.724 5.682 5.620 5.542 5.478 







  BC SULF CH4 SIR 
Tmt 
(ppb) Time (hours) 
  241 527.5 622 750 876 989.5 1091.5 1182.5 1278 1376 1470 1588.5 1687.5 1784 1925.5 2045 2190 2358 2502 2643 
  mg CH4-C Kg-1 dry soil Day 
1 0.000 0.000 0.000 0.001 0.001 0.002 0.003 0.012 0.077 0.503 1.180 1.496 1.709 1.956 3.307 4.621 4.800 5.018 5.256 5.098 
50 0.000 0.000 0.000 0.001 0.002 0.002 0.005 0.012 0.028 0.072 0.252 0.879 1.868 2.860 4.979 6.392 6.300 6.586 6.548 6.353 
100 0.000 0.000 0.000 0.001 0.001 0.002 0.003 0.008 0.016 0.037 0.091 0.274 0.786 1.815 4.443 4.953 5.237 5.390 5.435 5.394 
500 0.000 0.000 0.000 0.000 0.001 0.001 0.001 0.002 0.004 0.008 0.022 0.067 0.229 0.432 1.478 3.055 4.425 5.199 6.139 6.305 
1000 0.000 0.000 0.001 0.001 0.002 0.002 0.003 0.007 0.015 0.038 0.383 0.284 0.948 1.799 3.732 4.646 5.181 5.562 5.666 5.722 















Table A-D.3. Average concentrations of BR methane evolved at each time interval for CIP 
(a), TET (b) and SULF (c) in the peat soil 
a) 
 
DP CIP CH4 BR 
Tmt 
(ppb) Time (hours) 
 
48 73 95.5 168 241.5 430.5 598.5 764.5 1100.5 1436 
 
mg CH4-C Kg-1 dry soil Day 
1 0.028 0.027 0.024 0.029 0.039 0.078 0.100 0.081 0.107 0.121 
50 0.024 0.031 0.027 0.032 0.049 0.094 0.116 0.142 0.169 0.182 
100 0.024 0.024 0.025 0.035 0.044 0.084 0.105 0.109 0.162 0.158 
500 0.020 0.022 0.023 0.033 0.044 0.078 0.099 0.122 0.145 0.160 
100 0.017 0.018 0.020 0.024 0.035 0.067 0.096 0.114 0.145 0.142 




DP TET CH4 BR 
Tmt 
(ppb) Time (hours) 
 
204.5 539.5 871.5 1189.5 
  mg CH4-C Kg-1 dry soil Day 
1 0.121 0.232 0.260 0.288 
50 0.235 0.394 0.451 0.465 
100 0.163 0.278 0.364 0.374 
500 0.169 0.329 0.392 0.415 
1000 0.118 0.234 0.247 0.257 












DP SULF CH4 BR 
Tmt 
(ppb) Time (hours) 
 
210 546.5 860 1194 
 
mg CH4-C Kg-1 dry soil Day 
1 0.107 0.184 0.215 0.207 
50 0.141 0.201 0.208 0.233 
100 0.122 0.205 0.217 0.222 
500 0.193 0.323 0.331 0.378 
1000 0.163 0.272 0.306 0.336 
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Table A-D.4. Average concentrations of SIR methane evolved at each time interval for CIP (a), TET (b) and SULF (c) in the peat 
soil 
a) 
  DP CIP CH4 SIR 
Tmt 
(ppb) Time (hours) 
 
23 29 79.5 93.5 143 168 199 217.5 238.5 262.5 287 318 334 358 388 409 433 454.5 504.5 553 599 650.5 
  mg CH4-C Kg-1 dry soil Day 
1 0.004 0.003 0.014 0.020 0.068 0.157 0.315 0.404 0.568 0.801 1.070 1.455 1.694 1.873 2.257 2.365 2.234 2.353 3.173 4.078 4.370 4.452 
50 0.007 0.005 0.022 0.029 0.080 0.137 0.292 0.405 0.542 0.823 1.067 1.535 1.705 1.939 2.284 2.380 2.644 2.806 3.656 4.668 4.705 4.380 
100 0.007 0.005 0.023 0.029 0.091 0.169 0.389 0.501 0.668 0.997 1.120 1.641 1.762 2.233 2.498 2.632 2.858 3.065 3.985 4.915 5.357 5.051 
500 0.009 0.006 0.020 0.030 0.097 0.212 0.442 0.583 0.838 1.222 1.665 2.335 2.406 2.768 3.287 3.261 3.440 3.531 4.342 4.871 4.827 4.542 
100 0.006 0.004 0.019 0.021 0.077 0.145 0.299 0.403 0.563 0.805 1.058 1.337 1.381 1.642 2.000 2.197 2.185 2.500 3.255 3.974 4.114 4.032 




DP TET CH4 SIR 
Tmt 
(ppb) Time (hours) 
 
30 72.5 121.5 167.5 217 266 313 363 409.5 458 531 601 647.5 719 
  mg CH4-C Kg-1 dry soil Day 
1 0.013 0.029 0.058 0.144 0.401 1.078 1.614 2.216 2.127 2.544 3.189 3.383 3.754 4.245 
50 0.008 0.024 0.074 0.175 0.484 1.265 1.801 2.328 2.249 2.791 3.217 3.426 3.853 4.450 
100 0.009 0.022 0.055 0.133 0.389 1.075 1.536 2.106 2.175 2.656 3.260 3.769 4.095 4.891 
500 0.018 0.045 0.089 0.211 0.590 1.432 1.976 2.539 2.663 3.110 3.921 4.322 4.740 5.570 
1000 0.018 0.039 0.074 0.169 0.440 1.288 1.821 2.521 2.635 3.153 3.827 4.159 4.467 5.036 






DP SULF CH4 SIR 
Tmt 
(ppb) Time (hours) 
 
30.5 72.5 120.5 166 216 266 312 362 410 458 531 601 647.5 719 
  mg CH4-C Kg-1 dry soil Day 
1 0.008 0.024 0.056 0.120 0.332 0.976 1.540 2.120 1.814 2.325 2.965 3.284 3.717 4.416 
50 0.011 0.031 0.063 0.147 0.376 1.054 1.662 2.418 2.593 3.151 3.703 4.099 4.454 4.648 
100 0.015 0.048 0.092 0.233 0.506 1.251 1.827 2.366 2.540 3.198 3.656 4.297 4.632 5.209 
500 0.020 0.040 0.090 0.204 0.578 1.460 2.184 2.892 3.054 3.688 4.325 5.146 5.399 6.043 
1000 0.021 0.043 0.085 0.191 0.468 1.113 1.588 1.949 2.244 2.588 2.759 3.310 3.799 4.216 









(table cont.)  
120 
 
Table A-D.5. Average concentrations of BR carbon dioxide evolved at each time interval 
for CIP (a), TET (b) and SULF (c) in the mineral soil 
a) 
 
BC CIP CO2 BR 
Tmt 
(ppb) Time (hours) 
 
24.5 189.5 528 862 1175.5 
  mg CO2-C Kg-1 dry soil Day 
1 0.005 0.014 0.024 0.048 0.042 
50 0.013 0.023 0.032 0.053 0.054 
100 0.014 0.026 0.035 0.059 0.052 
500 0.008 0.021 0.034 0.066 0.052 
100 0.007 0.022 0.031 0.060 0.054 
BLK 0.007 0.017 0.033 0.060 0.058 
b) 
 
BC TET CO2 BR 
Tmt 
(ppb) Time (hours) 
 
26 193.5 525.5 860 1172.5 
  mg CO2-C Kg-1 dry soil Day 
1 0.005 0.016 0.021 0.043 0.042 
50 0.006 0.021 0.030 0.049 0.047 
100 0.006 0.017 0.026 0.054 0.056 
500 0.009 0.023 0.034 0.061 0.063 
1000 0.007 0.017 0.023 0.046 0.043 













BC SULF CO2 BR 
Tmt 
(ppb) Time (hours) 
 
25.5 192.5 542.5 860 1169.5 
  mg CO2-C Kg-1 dry soil Day 
1 0.006 0.022 0.029 0.051 0.044 
50 0.007 0.024 0.027 0.048 0.043 
100 0.006 0.019 0.020 0.045 0.041 
500 0.005 0.013 0.015 0.032 0.031 
1000 0.004 0.010 0.013 0.036 0.032 
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Table A-D.6. Average concentrations of SIR carbon dioxide evolved at each time interval 
for CIP (a), TET (b) and SULF (c) in the mineral soil 
a) 
 
BC CIP CO2 SIR 
Tmt 
(ppb) Time (hours) 
 
18 43.5 64.5 92 114 137.5 
  mg CO2-C Kg-1 dry soil Day 
1 0.012 0.963 2.218 3.518 3.898 3.994 
50 0.013 1.008 2.071 3.477 3.944 4.048 
100 0.012 1.123 2.149 3.693 4.049 4.128 
500 0.009 1.171 2.419 3.837 4.218 4.303 
1000 0.009 0.894 2.023 3.485 4.115 4.220 
BLK 0.010 0.822 1.948 3.338 3.892 3.983 
b) 
 
BC TET CO2 SIR 
Tmt 
(ppb) Time (hours) 
 
19 44 65.5 95 116.5 139 
  mg CO2-C Kg-1 dry soil Day 
1 0.020 1.190 2.235 3.735 4.347 4.453 
50 0.023 1.364 2.595 4.123 4.523 4.627 
100 0.020 1.410 2.705 4.064 4.551 4.640 
500 0.019 1.057 2.300 4.071 4.413 4.488 
1000 0.021 1.232 2.589 4.505 4.783 4.850 
BLK 0.018 0.913 2.263 4.095 4.539 4.613 
c) 
 
BC SULF CO2 SIR 
Tmt 
(ppb) Time (hours) 
 
20.5 45 66 93.5 116.5 140 161 185 
  mg CO2-C Kg-1 dry soil Day 
1 0.034 1.086 2.231 3.682 4.632 4.850 4.911 4.919 
50 0.015 0.756 1.969 3.357 4.321 4.509 4.571 4.576 
100 0.012 0.471 1.697 3.359 4.239 4.377 4.428 4.433 
500 0.007 0.049 0.258 1.328 3.039 4.003 4.198 4.172 
1000 0.005 0.044 0.398 1.539 3.224 4.299 4.486 4.470 
BLK 0.025 0.997 2.032 3.519 4.303 4.541 4.618 4.625 
123 
 




DP CIP CO2 BR 
Tmt 
(ppb) Time (hours) 
 
2.5 8 21 27 48 71.5 95 166 242 434 602 765 1103.5 1438.5 
  mg CO2-C Kg-1 dry soil Day 
1 0.010 0.006 0.010 0.008 0.012 0.014 0.012 0.012 0.021 0.043 0.058 0.095 0.079 0.100 
50 0.012 0.012 0.011 0.010 0.012 0.009 0.009 0.014 0.016 0.036 0.046 0.087 0.071 0.091 
100 0.010 0.011 0.011 0.012 0.015 0.010 0.010 0.017 0.019 0.043 0.046 0.089 0.077 0.108 
500 0.012 0.009 0.009 0.007 0.009 0.030 0.034 0.042 0.049 0.071 0.091 0.169 0.113 0.153 
100 0.011 0.012 0.012 0.010 0.013 0.009 0.011 0.016 0.021 0.040 0.056 0.110 0.071 0.120 
BLK 0.009 0.009 0.011 0.011 0.012 0.010 0.010 0.015 0.021 0.045 0.055 0.102 0.083 0.103 
b) 
 
DP TET CO2 BR 
Tmt 
(ppb) Time (hours) 
 
42.5 204.5 543.5 876 1191.5 
  mg CO2-C Kg-1 dry soil Day 
1 0.029 0.065 0.122 0.160 0.168 
50 0.044 0.126 0.202 0.277 0.258 
100 0.035 0.104 0.186 0.246 0.240 
500 0.031 0.121 0.210 0.275 0.273 
1000 0.027 0.065 0.132 0.146 0.150 






DP SULF CO2 BR 
Tmt 
(ppb) Time (hours) 
 
46 209 545 852.5 1187 
  mg CO2-C Kg-1 dry soil Day 
1 0.03446 0.06569 0.11512 0.13033 0.11901 
50 0.04001 0.07261 0.11127 0.13345 0.12152 
100 0.032 0.06505 0.10342 0.12519 0.12264 
500 0.03981 0.09872 0.16031 0.19714 0.20262 
1000 0.0373 0.08598 0.14148 0.17815 0.1694 
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Table A-D.8. Average concentrations of SIR carbon dioxide evolved at each time interval 
for CIP (a), TET (b) and SULF (c) in the peat soil 
a) 
 
DP CIP CO2 SIR 
Tmt 
(ppb) Time (hours) 
 
3.5 9 21.5 27.5 49 72.5 94 127 151 
  mg CO2-C Kg-1 dry soil Day 
1 0.016 0.053 0.118 0.181 1.161 2.940 4.127 5.180 5.729 
50 0.015 0.055 0.115 0.160 0.936 2.864 4.170 5.248 5.674 
100 0.018 0.067 0.136 0.214 1.430 2.883 3.714 4.630 4.992 
500 0.010 0.049 0.129 0.225 1.326 2.982 3.933 4.321 4.388 
100 0.009 0.043 0.096 0.126 1.370 3.182 4.312 5.354 5.787 
BLK 0.037 0.066 0.155 0.210 1.500 3.290 4.489 5.550 5.816 
b) 
 
DP TET CO2 SIR 
Tmt 
(ppb) Time (hours) 
 
9 26.5 49.5 74.5 96 121 144 171.5 
  mg CO2-C Kg-1 dry soil Day 
1 0.041 0.083 0.646 1.890 2.885 3.517 3.840 3.800 
50 0.029 0.120 0.781 1.745 2.327 2.892 3.247 3.333 
100 0.023 0.096 0.683 1.880 2.787 3.461 3.767 3.792 
500 0.036 0.106 0.805 1.885 2.770 3.549 3.976 3.981 
1000 0.027 0.100 0.695 1.956 2.928 3.546 3.839 3.793 













DP SULF CO2 SIR 
Tmt 
(ppb) Time (hours) 
 
5 25 51 73.5 97 117.5 144.5 167 
  mg CO2-C Kg-1 dry soil Day 
1 0.008 0.072 0.538 1.207 2.029 2.998 3.831 3.888 
50 0.011 0.088 0.661 1.478 2.337 3.166 3.796 3.902 
100 0.006 0.080 0.626 1.371 2.182 2.966 3.633 3.701 
500 0.009 0.120 0.611 1.576 2.611 3.649 4.187 4.197 
1000 0.010 0.113 0.538 1.444 2.498 3.570 4.120 4.071 
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Table A-D.9. Average concentrations of SIR nitrous oxide evolved at each time interval for 
CIP (a), TET (b) and SULF (c) in the mineral soil 
a) 
 
BC CIP N2O SIR 
Tmt 
(ppb) Time (hours) 
 
2 25 47.5 59.5 71 96.5 120 
  mg N2O-N Kg-1 dry soil Day 
1 0.000 0.011 0.028 0.065 0.115 0.281 0.386 
50 0.000 0.010 0.022 0.035 0.074 0.235 0.423 
100 0.001 0.019 0.036 0.057 0.093 0.298 0.374 
500 0.001 0.019 0.034 0.055 0.092 0.299 0.368 
1000 0.001 0.019 0.034 0.053 0.084 0.205 0.457 
BLK 0.001 0.021 0.036 0.067 0.138 0.384 0.512 
b) 
 
BC TET N2O SIR 
Tmt 
(ppb) Time (hours) 
 
4 27 47.5 57.5 77 99 119 
  mg N2O-N Kg-1 dry soil Day 
1 0.002 0.030 0.149 0.276 0.949 2.770 4.546 
50 0.002 0.028 0.106 0.325 0.911 2.821 4.102 
100 0.002 0.028 0.121 0.273 0.770 2.860 4.053 
500 0.002 0.028 0.121 0.198 0.911 3.151 4.939 
1000 0.002 0.028 0.127 0.127 1.061 2.849 4.289 













BC SULF N2O SIR 
Tmt 
(ppb) Time (hours) 
 
2 26.5 47.5 57 73.5 95.5 117 
  mg N2O-N Kg-1 dry soil Day 
1 0.001 0.036 0.211 0.460 0.834 2.270 3.562 
50 0.001 0.032 0.093 0.253 0.577 2.315 4.129 
100 0.001 0.037 0.113 0.290 0.631 2.080 3.382 
500 0.002 0.031 0.070 0.121 0.300 0.908 1.656 
1000 0.001 0.030 0.071 0.089 0.227 0.683 1.097 
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Table A-D.10. Average concentrations of SIR nitrous oxide evolved at each time interval 
for CIP (a), TET (b) and SULF (c) in the peat soil 
a) 
 
DP CIP N2O SIR 
Tmt 
(ppb) Time (hours) 
 
3.5 26.5 49 60.5 72.5 98.5 122.5 142.5 
  mg N2O-N Kg-1 dry soil Day 
1 0.001 0.018 0.034 0.045 0.057 0.184 0.335 0.767 
50 0.001 0.016 0.028 0.040 0.085 0.459 0.464 0.616 
100 0.001 0.018 0.034 0.059 0.086 0.225 0.793 1.532 
500 0.002 0.016 0.038 0.091 0.177 0.329 0.880 1.507 
1000 0.001 0.015 0.033 0.070 0.156 0.376 1.086 1.744 
BLK 0.001 0.014 0.029 0.065 0.147 0.333 0.650 1.762 
b) 
 
DP TET N2O SIR 
Tmt 
(ppb) Time (hours) 
 
2 24 48 60 72 96 120 
  mg N2O-N Kg-1 dry soil Day 
1 0.000 0.029 0.049 0.085 0.324 1.401 1.881 
50 0.000 0.029 0.059 0.128 0.512 1.628 3.219 
100 0.000 0.030 0.100 0.236 0.800 1.822 2.648 
500 0.000 0.027 0.068 0.140 0.695 1.939 2.379 
1000 0.000 0.026 0.064 0.135 0.610 1.685 2.202 













DP SULF N2O SIR 
Tmt 
(ppb) Time (hours) 
 
2 24 48 72 96 
  mg N2O-N Kg-1 dry soil Day 
1 0.000 0.036 0.160 0.588 1.254 
50 0.000 0.032 0.051 0.530 1.447 
100 0.000 0.032 0.052 0.453 1.476 
500 0.001 0.034 0.064 0.446 1.348 
1000 0.000 0.032 0.053 0.437 1.389 
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